Suchen und Finden
Front cover
1
Title page
5
Copyright page
6
Table of contents
7
Contributors
21
Preface
41
Foreword
45
I: Plant Peptides Section
47
1: 4-kDa Peptide
47
ABSTRACT
47
DISCOVERY
47
STRUCTURE OF THE PRECURSOR mRNA/GENE
47
DISTRIBUTION OF THE mRNA
47
PROCESSING
48
RECEPTORS
48
ACTIVE AND/OR SOLUTION CONFORMATION
48
BIOLOGICAL ACTIONS
48
References
50
2: AtPep1 Peptides
51
ABSTRACT
51
DISCOVERY
51
STRUCTURE OF AtPep1 AND THE GENE ENCODING THE PRECURSOR PROTEIN ProAtPep1
51
DISTRIBUTION OF ProAtPep1 mRNA
52
PROCESSING OF ProAtPep1
53
AtPep1 RECEPTOR
53
SOLUTION CONFORMATION
53
BIOLOGICAL ACTIONS OF AtPep1
53
Acknowledgments
54
References
54
3: CLAVATA3: A Putative Peptide Ligand Controlling Arabidopsis Stem Cell Specification
55
ABSTRACT
55
DISCOVERY
55
STRUCTURE OF THE PRECURSOR mRNA/GENE
56
RECEPTORS
58
BIOLOGICAL ACTIONS
59
References
60
4: DVL Peptides Are Involved in Plant Development
63
ABSTRACT
63
DISCOVERY
63
STRUCTURE OF THE PRECURSOR mRNA/GENE
64
DISTRIBUTION OF THE DVL1 mRNA
64
PROCESSING
65
RECEPTORS
66
BIOLOGICAL ACTION
66
References
67
5: The POLARIS Peptide
69
ABSTRACT
69
DISCOVERY
69
STRUCTURE OF THE PRECURSOR mRNA/GENE
71
DISTRIBUTION OF THE mRNA
71
PROCESSING
72
BIOLOGICAL ACTIONS
72
References
73
6: Phytosulfokine
75
ABSTRACT
75
INTRODUCTION
75
DISCOVERY AND BIOLOGICAL ACTIONS
75
STRUCTURE OF THE PRECURSOR mRNA/GENE
76
TYROSINE SULFATION
77
RECEPTORS
77
CONCLUSION
77
Acknowledgments
78
References
78
7: RALF Peptides
79
ABSTRACT
79
DISCOVERY
79
STRUCTURE OF THE RALF PEPTIDE AND ITS PRECURSOR cDNA AND GENE
79
DISTRIBUTION OF THE mRNA
80
PROCESSING
80
RECEPTOR
80
SOLUTION CONFORMATION OF RALF
81
BIOLOGICAL ACTION OF RALF
81
Acknowledgment
81
References
82
8: ROTUNDIFOLIA4: A Plant-Specific Small Peptide
83
ABSTRACT
83
DISCOVERY
83
STRUCTURE OF THE PRECURSOR mRNA/GENE
83
DISTRIBUTION OF THE mRNA
84
PROCESSING
84
RECEPTORS
85
BIOLOGICAL ACTIONS
85
References
86
9: The S-Locus Cysteine-Rich Peptide SCR/SP11
87
ABSTRACT
87
DISCOVERY OF SCR
87
STRUCTURE OF THE PRECURSOR mRNA/GENE
89
DISTRIBUTION OF THE mRNA
89
PROCESSING OF THE SCR PROTEIN
90
THE SCR RECEPTOR
90
STRUCTURE
90
BIOLOGICAL ACTIONS
92
References
92
10: Systemins
95
ABSTRACT
95
DISCOVERY OF SYSTEMINS
95
STRUCTURES OF SYSTEMINS AND OF THEIR PRECURSOR cDNAs
96
DISTRIBUTION OF SYSTEMIN SUBFAMILY mRNAs
97
PROCESSING OF THE SYSTEMIN FAMILY PRECURSOR PROTEINS
97
THE LeSys RECEPTOR
98
SOLUTION CONFORMATIONS OF SYSTEMIN SUBFAMILY MEMBERS
98
BIOLOGICAL ACTIONS OF SYSTEMIN FAMILY MEMBERS
98
Acknowledgments
99
References
99
II: Bacterial/Antibiotic Peptides Section
101
11: Cationic Antimicrobial Peptides—The Defensins
101
ABSTRACT
101
DISCOVERY
101
STRUCTURE OF THE PRECURSOR mRNA/GENE
101
DISTRIBUTION AND EXPRESSION OF THE mRNA
102
PROCESSING
104
RECEPTORS
104
ACTIVE CONFORMATION
105
BIOLOGICAL ACTIONS
105
Acknowledgments
111
References
111
12: Cathelicidins: Cationic Host Defense and Antimicrobial Peptides
113
ABSTRACT
113
DISCOVERY
113
STRUCTURE OF THE PRECURSOR mRNA/STRUCTURAL GENE
113
DISTRIBUTION OF CATHELICIDINS
114
PROCESSING
114
RECEPTORS
115
ACTIVE AND/OR SOLUTION CONFORMATION
116
BIOLOGICAL FUNCTIONS
117
Acknowledgments
118
References
118
13: Microcins
121
ABSTRACT
121
DISCOVERY
121
STRUCTURE OF THE PRECURSOR mRNA/STRUCTURAL GENE
121
DISTRIBUTION OF THE mRNA
122
PROCESSING
122
RECEPTORS
124
ACTIVE AND/OR SOLUTION CONFORMATION
124
BIOLOGICAL ACTIONS
125
Acknowledgments
125
References
125
14: Peptaibols
129
ABSTRACT
129
INTRODUCTION
129
CHARACTERISTIC FEATURES OF THE PEPTAIBOLS
129
BIOLOGICAL ORIGINS AND BIOSYNTHESIS OF PEPTAIBOLS
131
PEPTAIBOL STRUCTURES
131
FUNCTIONS AND ACTIVITIES OF PEPTAIBOLS
132
Acknowledgments
133
References
133
15: Nonribosomally Synthesized Microbial Macrocyclic Peptides
135
ABSTRACT
135
STRUCTURAL DIVERSITY OF NRPS SYNTHESIZED PEPTIDES
135
MODULAR STRUCTURE OF NRPSs
136
MACROCYCLIZATION
138
STRUCTURE OF THE SURFACTIN THIOESTERASE DOMAIN
138
BIOCHEMICAL CHARACTERIZATION OF EXCISED THIOESTERASE DOMAINS
139
CHEMOENZYMATIC APPROACHES TOWARD NOVEL CYCLOPEPTIDES
140
THE COMBINATORIAL POTENTIAL OF TE DOMAINS TO SYNTHESIZE CYCLIC PEPTIDE LIBRARIES
141
Acknowledgments
141
References
141
16: Lantibiotics
143
ABSTRACT
143
DISCOVERY
143
STRUCTURE OF THE PRECURSOR mRNA/GENE
143
DISTRIBUTION OF THE mRNA
143
PROCESSING
144
RECEPTORS
144
ACTIVE AND/OR SOLUTION CONFORMATION
144
BIOLOGICAL ACTIONS
146
Acknowledgments
149
References
149
17: The Nonlantibiotic Heat-Stable Bacteriocins in Gram-Positive Bacteria
153
ABSTRACT
153
DISCOVERY
153
SYNTHESIS
153
BIOLOGICAL ACTIONS AND RECEPTORS
156
STRUCTURE
157
FUTURE TRENDS
158
Acknowledgments
158
References
158
18: Colicins: Bacterial/Antibiotic Peptides
161
ABSTRACT
161
DISCOVERY AND CLASSIFICATION
161
STRUCTURE OF THE PRECURSOR mRNA/GENE
161
THE DOMAIN CONCEPT
162
SEQUENCE COMPARISONS
163
X-RAY STRUCTURES OF COLICINS
166
MECHANISM OF IMPORT ACROSS OUTER MEMBRANE
168
AREAS OF RESEARCH ENCOMPASSED BY COLICIN STUDIES
168
Acknowledgment
168
References
168
III: Fungal/Antifungal Peptides Section
171
19: Fungal Peptides with Antifungal Activity
171
ABSTRACT
171
DISCOVERY
171
STRUCTURE
173
BIOLOGICAL ACTION
174
References
174
20: Toxins from Basidiomycete Fungi (Mushroom): Amatoxins, Phallotoxins, and Virotoxins
177
ABSTRACT
177
INTRODUCTION
177
DISCOVERY OF MUSHROOM TOXINS
177
STRUCTURES OF MUSHROOM TOXINS
179
TOXIC ACTIONS OF MUSHROOM TOXINS
179
Acknowledgments
181
References
181
21: Fungal Peptides with Ribonuclease Activity
183
ABSTRACT
183
DISCOVERY
183
STRUCTURE
183
BIOLOGICAL ACTION
185
References
189
22: Fungal Ribosome Inactivating Proteins
191
ABSTRACT
191
DISCOVERY
191
STRUCTURE
192
BIOLOGICAL ACTIONS
192
Acknowledgments
194
References
194
23: Peptides and Depsipeptides from Plant Pathogenic Fungi
197
ABSTRACT
197
PHYTOTOXINS
197
DEPSIPEPTIDES AND PEPTIDES
198
CONCLUSION
201
References
202
IV: Invertebrate Peptides Section
203
24: Insect Diuretic and Antidiuretic Hormones
203
ABSTRACT
203
DISCOVERY
203
STRUCTURE OF THE PRECURSOR mRNA/GENE
204
DISTRIBUTION OF mRNA AND PEPTIDES
205
PEPTIDE PROCESSING
205
RECEPTORS
205
STRUCTURE-ACTIVITY AND ACTIVE CONFORMATION
206
BIOLOGICAL ACTIONS
206
CONCLUSION
207
References
207
25: Developmental Peptides: ETH, Corazonin, and PTTH
209
ABSTRACT
209
DISCOVERY
209
STRUCTURE OF THE PRECURSOR mRNA/GENE AND PEPTIDE PROCESSING
210
PTTH
211
DISTRIBUTION OF THE mRNA AND PEPTIDES
212
PTTH
212
RECEPTORS
212
ACTIVE AND/OR SOLUTION CONFORMATION
213
BIOLOGICAL ACTIONS
213
PTTH
214
References
214
26: Tachykinins and Tachykinin-Related Peptides in Invertebrates
217
ABSTRACT
217
DISCOVERY
217
STRUCTURE OF THE PRECURSOR mRNA/GENE
218
DISTRIBUTION OF mRNA AND PEPTIDES
219
PEPTIDE PROCESSING
220
RECEPTORS OF TKRPs
220
STRUCTURE-ACTIVITY AND ACTIVE CONFORMATION
221
BIOLOGICAL ACTIONS
221
CONCLUSION
221
References
222
27: Proctolin in Insects
223
ABSTRACT
223
DISCOVERY
223
STRUCTURE OF THE PRECURSOR mRNA/GENE
223
DISTRIBUTION OF mRNA
223
PROCESSING
224
RECEPTORS
225
STRUCTURE—ACTIVITY AND ACTIVE CONFORMATION
225
BIOLOGICAL ACTIONS
226
References
227
28: Sulfakinins
229
ABSTRACT
229
DISCOVERY
229
STRUCTURE OF THE PRECURSOR mRNA/GENE
229
PROCESSING
230
TISSUE DISTRIBUTION
230
RECEPTORS
231
STRUCTURE/CONFORMATION-ACTIVITY RELATIONSHIPS
231
BIOLOGICAL ACTIONS
232
References
232
29: The Invertebrate AKH/RPCH Family
235
ABSTRACT
235
DISCOVERY
235
PEPTIDE AND PRECURSOR STRUCTURE AND PROCESSING
235
DISTRIBUTION
236
SOLUTION CONFORMATION OF AKH AND RECEPTORS FOR AKH
236
BIOLOGICAL ACTIONS
237
Acknowledgments
238
References
238
30: Insect Myosuppressins/FMRFamides and FL/IRFamides/NPFs
239
ABSTRACT
239
DISCOVERY
239
STRUCTURE OF THE PRECURSOR mRNA/GENE
240
DISTRIBUTION OF mRNA
241
PROCESSING
242
RECEPTORS
242
STRUCTURE–ACTIVITY AND ACTIVE CONFORMATION
243
BIOLOGICAL ACTION
244
References
245
31: Allatostatins in the Insects
247
ABSTRACT
247
DISCOVERY
247
STRUCTURE OF ALLATOSTATIN PRECURSORS
247
DISTRIBUTION OF mRNA AND PEPTIDES
248
PEPTIDE PROCESSING
249
ALLATOSTATIN RECEPTORS
249
STRUCTURE–ACTIVITY AND ACTIVE CONFORMATIONS
250
BIOLOGICAL ACTIONS
251
CONCLUSION
251
References
251
32: The FXPRLamide (Pyrokinin/PBAN) Peptide Family
253
ABSTRACT
253
DISCOVERY
253
STRUCTURE OF THE PRECURSOR mRNA/GENE
253
DISTRIBUTION OF mRNA AND PEPTIDES
254
PEPTIDE PROCESSING
255
RECEPTORS OF IXPRLamides
256
STRUCTURE–ACTIVITY RELATIONSHIPS AND ACTIVE CONFORMATION
256
BIOLOGICAL ACTIONS
257
References
257
33: Insect Pigment Dispersing Factor and Bursicon
259
ABSTRACT
259
INSECT PIGMENT DISPERSING FACTOR
259
BURSICON
261
References
265
34: Crustacean Bioactive Peptides
267
ABSTRACT
267
INTRODUCTION
267
PROCTOLIN
267
CRUSTACEAN CARDIOACTIVE PEPTIDE
267
SULFAKININS
270
NEUROPEPTIDE F
270
OPIOID–ENKEPHALIN
270
ORCOKININ AND ORCOMYOTROPIN
271
ALLATOSTATIN
271
TACHYKININ-RELATED PEPTIDES
272
KININS
272
PYROKININ/PBAN
272
SIFAMIDE
272
MISCELLANEOUS
273
References
273
35: Crustacean Chromatophorotrophins and Hyperglycemic Hormone Peptide Families
275
ABSTRACT
275
INTRODUCTION
275
CHROMATOPHOROTROPHIC HORMONES
275
CRUSTACEAN HYPERGLYCEMIC HORMONES
276
References
279
36: Molluscan Bioactive Peptides
281
ABSTRACT
281
FMRFamide, FMRFamide-RELATED PEPTIDES (FaRPs)
281
PEPTIDES AND METABOLISM: ENERGY FLOW AND GROWTH
282
PEPTIDES AND FEEDING BEHAVIOR
283
PEPTIDES AND RENAL FUNCTION
284
TACHYKININS
284
References
285
37: Molluscan Peptides and Reproduction
287
ABSTRACT
287
PEPTIDES AND REPRODUCTION
287
DISCOVERY
289
VP/OT: DISCOVERY
289
PHEROMONES: DISCOVERY
290
References
291
38: Free-Living Nematode Peptides
293
ABSTRACT
293
INTRODUCTION
293
FMRFamide-LIKE PEPTIDES (FLPs)
293
NEUROPEPTIDE-LIKE PEPTIDES (NLPs)
296
INSULINS (INSs)
296
ANTIMICROBIAL PEPTIDES
298
Acknowledgment
299
References
299
39: Parasitic Nematode Peptides
301
ABSTRACT
301
INTRODUCTION
301
FMRFamide-LIKE PEPTIDES (FLPs)
301
TKQELE
305
References
305
V: Amphibian Peptides Section
307
40: Amphibian Tachykinins
307
ABSTRACT
307
DISCOVERY
307
STRUCTURE OF THE PRECURSOR mRNA/GENE
308
AMPHIBIAN TK DISTRIBUTION
309
RECEPTORS
310
ACTIVE AND/OR SOLUTION CONFORMATION
310
BIOLOGICAL ACTIONS
310
PATHOLOGICAL IMPLICATIONS
313
References
313
41: Opioid Peptides from Frog Skin and Bv8-Related Peptides
315
ABSTRACT
315
OPIOID PEPTIDES
315
A BRIEF HISTORY
315
STRUCTURE AND CONFORMATION
316
BIOLOGICAL ACTIONS
317
Bv8/PROKINETICIN FAMILY (SWISS-PROT: Q9PW66)
318
References
320
42: Amphibian Bombesin-like Peptides
323
ABSTRACT
323
INTRODUCTION
323
AMPHIBIAN BOMBESINS
323
AMPHIBIAN PHYLLOLITORINS
325
RANATENSIN-LIKE PEPTIDES
325
GASTRIN-RELEASING PEPTIDE
326
PHYLOGENETIC CONSIDERATIONS AND IMPLICATIONS FOR ADDITIONAL MAMMALIAN BOMBESIN-LIKE PEPTIDES
326
References
327
43: Host Defense Peptides from Australian Amphibians: Caerulein and Other Neuropeptides
329
ABSTRACT
329
INTRODUCTION
329
THE CAERULEIN PEPTIDES
329
PEPTIDES RELATED TO CAERULEIN
331
TRYPTOPHYLLIN PEPTIDES
332
DISULFIDE NEUROPEPTIDES FROM THE GENUS CRINIA
333
Acknowledgments
333
References
333
44: Bradykinin-Related Peptides from Frog Skin
337
ABSTRACT
337
DISCOVERY AND DISTRIBUTION
337
BIOSYNTHESIS OF BRADYKININ AND RELATED PEPTIDES
337
MOLECULAR VARIANTS OF BK
338
BIOLOGICAL ACTIVITIES
339
References
340
45: The Dermaseptins
341
ABSTRACT
341
THE DERMASEPTIN SUPERFAMILY
341
THE PREPRODERMASEPTINS
343
ACTIVITIES OF THE PREPRODERMASEPTINDERIVED PEPTIDES
346
STRUCTURAL FEATURES AND MECHANISMS OF MICROBICIDAL ACTIVITY
347
References
349
46: The Temporins
351
ABSTRACT
351
DISCOVERY
351
BIOSYNTHESIS OF THE TEMPORINS
352
MOLECULAR HETEROGENEITY OF THE TEMPORINS
353
BIOLOGICAL ACTIVITIES OF THE TEMPORINS
353
POTENTIAL CLINICAL AND COMMERCIAL APPLICATIONS
354
References
354
47: Chromogranins/Secretogranins and Derived Peptides: Insights from the Amphibian Model
357
ABSTRACT
357
DISCOVERY
357
STRUCTURE OF THE PRECURSOR mRNA/GENE
357
DISTRIBUTION OF THE mRNA
360
BIOLOGICAL ACTIONS
362
Acknowledgments
364
References
364
48: Sodefrin and Related Pheromones
367
ABSTRACT
367
DISCOVERY
367
STRUCTURE OF THE PRECURSOR mRNA/GENE
368
DISTRIBUTION OF THE mRNA
369
PROCESSING OF THE PRECURSORS
369
RECEPTORS
369
STRUCTURE–ACTIVITY RELATIONSHIPS
371
BIOLOGICAL ACTIONS
371
PHYSIOLOGICAL IMPLICATION
372
References
372
49: Amphibian Neurohypophysial Peptides
373
ABSTRACT
373
DISCOVERY
373
STRUCTURE OF THE PRECURSOR mRNA/GENE
373
DISTRIBUTION OF AVT AND MT
374
RECEPTOR STRUCTURE AND DISTRIBUTION
374
MAJOR BIOLOGICAL ACTIONS OF AVT AND MT
374
STRUCTURE AND FUNCTION OF HYDRINS
375
References
376
50: Bombinins
379
ABSTRACT
379
DISCOVERY
379
SOLUTION CONFORMATION
381
STRUCTURE OF THE PRECURSOR mRNA/GENE
381
BIOLOGICAL ACTIVITY
381
MODE OF ACTION STUDIES
382
Acknowledgments
383
References
383
VI: Venom Peptides Section
385
51: Scorpion Venom Peptides
385
INTRODUCTION
385
DISCOVERY AND DOCUMENTED BIODIVERSITY
385
THREE-DIMENSIONAL FOLDING
386
SCORPION TOXIN PRECURSORS
387
RECEPTOR SITES
387
MOLECULAR BASIS OF THEIR ACTIVITY
387
CONCLUSION
389
Acknowledgments
389
References
389
52: Snake Venom Peptides
401
ABSTRACT
401
INTRODUCTION
401
THREE-FINGER TOXINS
401
PROTEASE INHIBITOR HOMOLOGS
404
CROTAMINE-LIKE MYOTOXINS
405
SARAFOTOXINS
405
CRISP FAMILY TOXINS
405
NATRIURETIC PEPTIDES
405
DISINTEGRINS
406
C-TYPE LECTINS AND LECTIN-LIKE PROTEINS
406
WAGLERINS
406
BRADYKININ-POTENTIATING PEPTIDES
406
AVIT PEPTIDES
407
MISCELLANEOUS PEPTIDES
407
References
408
53: Sea Anemone Venom Peptides
409
ABSTRACT
409
INTRODUCTION
409
ION CHANNEL BLOCKERS AND MODULATORS
409
CYTOLYSINS
411
OTHER BIOACTIVE PEPTIDES
412
Acknowledgments
412
References
412
54: Spider Venom Peptides
415
ABSTRACT
415
INTRODUCTION
415
METHODOLOGICAL APPROACHES IN THE ISOLATION OF NOVEL SPIDER VENOM PEPTIDES
415
STRUCTURE OF THE PRECURSOR SPIDER VENOM PEPTIDE AND POSTTRANSLATIONAL PROCESSING
416
STRUCTURAL ORGANIZATION OF SPIDER VENOM PEPTIDES: VARIATIONS ON AN ANCESTRAL FOLD
416
SPIDER PEPTIDE TOXINS MODULATING Nav CHANNEL FUNCTION: BLOCKERS AND GATING MODIFIERS
416
SPIDER PEPTIDE TOXINS MODULATING VOLTAGE-GATED POTASSIUM CHANNELS
420
SPIDER PEPTIDE TOXINS MODULATING ON Cav CHANNELS
421
SPIDER PEPTIDE TOXINS ACTING ON ACID-SENSING ION CHANNELS
422
SPIDER PEPTIDE TOXINS WITH NONSELECTIVE ACTIONS ON VOLTAGE-GATED ION CHANNELS: PROMISCUOUS TOXINS
422
SPIDER PEPTIDE TOXINS ACTING ON MECHANOSENSITIVE ION CHANNELS
422
SPIDER TOXINS ACTING ON GLUTAMATE RECEPTORS OR TRANSPORTERS
422
SPIDER TOXINS ACTING ON NEUROTRANSMITTER RELEASE (PRESYNAPTIC TOXINS)
423
SPHINGOMYELINASES D TOXINS FROM SPIDER VENOMS
423
ANTIMICROBIAL AND CYTOLYTIC PEPTIDE TOXINS FROM SPIDER VENOM
424
CONCLUSION
425
References
425
55: Conus Snail Venom Peptides
427
ABSTRACT
427
INTRODUCTION: THE BIODIVERSITY OF VENOMOUS MOLLUSCS
427
DISCOVERY OF CONOTOXINS
427
PRECURSOR STRUCTURE, EXPRESSION, AND PROCESSING: CONOTOXIN SUPERFAMILIES
428
DEFINITION OF CONOTOXIN FAMILIES, RECEPTOR TARGETS, STRUCTURES
430
BIOLOGICAL MECHANISMS, THERAPEUTIC APPLICATIONS
432
Acknowledgments
433
References
433
56: Insect Venom Peptides
435
ABSTRACT
435
INTRODUCTION
435
PEPTIDES FROM THE VENOMS OF SOCIAL HYMENOPTERA
436
PEPTIDE TOXINS FROM SOCIAL WASPS
437
PEPTIDES FROM THE VENOMS OF SOLITARY WASPS
438
PEPTIDES FROM ANT VENOMS
439
Aknowledgments
440
References
440
57: Worm Venom Peptides
443
ABSTRACT
443
INTRODUCTION
443
NEMERTINE PEPTIDE NEUROTOXINS
444
NEMERTINE PEPTIDE CYTOLYSINS
445
ANNELID (GLYCERA) NEUROTOXIN
445
PEPTIDE CYTOLYSINS FROM OTHER WORM PHYLA
446
CONCLUSION
446
References
446
58: Targets and Therapeutic Properties of Venom Peptides
449
ABSTRACT
449
ANTICOAGULANTS AND THROMBOLYTIC AGENTS
449
ANTIHYPERTENSIVE AGENTS
456
ANTIARRHYTHMIC AGENTS
456
CONGESTIVE HEART FAILURE
456
ANTIMICROBIAL PEPTIDES
456
IMMUNOMODULATORY PEPTIDES
457
ANTITUMOR PEPTIDES
457
ANALGESIA
458
DIABETES MELLITUS
458
Acknowledgments
458
References
458
59: Structure-Function Strategies to Improve the Pharmacological Value of Animal Toxins
461
ABSTRACT
461
CHEMICAL SYNTHESIS VERSUS GENETIC ENGINEERING
461
PEPTIDE IMPROVEMENT
461
DESIGN OF NOVEL PEPTIDE ANALOGS
462
BENEFITS OF SIZE REDUCTION IN PEPTIDES
462
RELEVANCE OF CHIMERA AND LABELING APPROACHES
462
STRATEGIES IMPLYING A CHANGE IN THE PATTERN OF HALF-CYSTINE PAIRS
463
WHAT ABOUT THE DIPOLE MOMENT OF VENOM PEPTIDES?
464
FUNCTIONAL DERIVATION OF VENOM PEPTIDES
464
IMPROVING PEPTIDE STABILITY
464
CONCLUSION
465
References
465
VII: Cancer/Anticancer Peptides Section
467
60: Analogs of Luteinizing Hormone-Releasing Hormone (LHRH) in Cancer
467
ABSTRACT
467
INTRODUCTION
467
ANTAGONISTS OF LHRH
468
RECEPTORS FOR LHRH ON TUMORS
468
CYTOTOXIC LHRH ANALOGS
469
EFFECTS OF ANALOGS OF LHRH ON TUMORS
469
CYTOTOXIC ANALOGS OF LHRH
469
SIDE EFFECTS OF CYTOTOXIC LHRH ANALOGS
471
CONCLUSION
472
References
472
61: Bombesin-Related Peptides and Neurotensin: Effects on Cancer Growth/Proliferation and Cellular Signaling in Cancer
475
ABSTRACT
475
INTRODUCTION
475
BN-RELATED PEPTIDES (GRP, NMB)
475
NEUROTENSIN (NT)
477
References
478
62: Somatostatin and NPY
481
ABSTRACT
481
INTRODUCTION
481
SOMATOSTATIN
481
NPY
484
References
486
63: Bradykinin and Cancer
489
ABSTRACT
489
INTRODUCTION
489
KININ CHEMISTRY AND BIOLOGY
489
BRADYKININ ANTAGONISTS
490
BRADYKININ AND CANCER
491
References
492
64: Endothelin
493
ABSTRACT
493
ENDOTHELIN-1
493
ET-1 ASSOCIATED SIGNAL TRANSDUCTION PATHWAYS
493
ENDOTHELIN EXPRESSION IN CANCER
493
ENDOTHELIN RECEPTOR EXPRESSION IN CANCER
494
ENDOTHELIN AS A MITOGEN
495
ENDOTHELIN AND APOPTOSIS
495
ENDOTHELIN AND ANGIOGENESIS
495
ENDOTHELIN-1 AND TUMOR PROGRESSION/METASTASES
496
ENDOTHELIN ANTAGONISM IN VIVO
496
CLINICAL TRIALS
496
References
496
65: Adrenomedullin: An Esoteric Juggernaut of Human Cancers
499
ABSTRACT
499
INTRODUCTION
499
AM EXPRESSION
499
GROWTH REGULATION
500
ANTIAPOPTOSIS
500
MIGRATION/INVASION
501
ANGIOGENESIS
501
IMMUNE REGULATION
501
THERAPEUTIC STRATEGIES AND CONCLUSION
502
References
502
66: Angiotensin Peptides and Cancer
505
ABSTRACT
505
INTRODUCTION
505
ACE AND AT1 RECEPTOR POLYMORPHISMS AND CANCER
506
EFFECTS OF ACE INHIBITORS AND ARBs ON CANCER CELL GROWTH AND TUMORIGENESIS
506
MECHANISMS OF ACTION OF ANG II
507
INHIBITION OF HUMAN CANCER CELL GROWTH BY ANG-(1-7)
508
CONCLUSION
509
References
509
67: Gastrin and Cancer
513
ABSTRACT
513
INTRODUCTION
513
EXPRESSION OF GASTRINS IN NORMAL TISSUE
513
THE GASTRIN RECEPTOR(S)
514
EXPRESSION OF GASTRIN IN TUMORS
514
GASTRIN AS A TUMOR GROWTH FACTOR
515
CONCLUSION
515
References
516
68: VIP and PACAP as Autocrine Growth Factors in Breast and Lung Cancer
519
ABSTRACT
519
INTRODUCTION
519
VIP/PACAP PEPTIDES
519
VIP RECEPTORS
520
SECOND MESSENGERS
520
PROLIFERATION
521
TUMOR IMAGING
521
CONCLUSION
521
References
522
69: Oxytocin and Cancer
525
ABSTRACT
525
MOVING FROM PHYSIOLOGY TO NEOPLASTIC PATHOLOGY
525
OT AS A MODULATOR OF CELL GROWTH IN OTR-EXPRESSING TUMORS
526
THE OT/OTR SYSTEM AND CANCER
527
References
527
70: Antagonists of Growth Hormone–Releasing Hormone (GHRH) in Cancer
529
ABSTRACT
529
INTRODUCTION
529
THERAPEUTIC INDICATIONS OF GHRH ANTAGONISTS
530
ANTAGONISTIC ANALOGS OF GHRH
530
GHRH AND GHRH RECEPTORS IN HUMAN CANCERS
531
MECHANISMS OF TUMOR INHIBITION BY GHRH ANTAGONISTS
532
INHIBITORY EFFECTS OF GHRH ANTAGONISTS ON HUMAN EXPERIMENTAL CANCERS IN VIVO
532
CONCLUSION
533
References
534
VIII: Vaccine Peptides Section
537
71: Cancer Immunotherapy with Rationally Designed Synthetic Peptides
537
ABSTRACT
537
CANCER IMMUNOTHERAPY
537
CURRENT VACCINATION STRATEGIES
538
ACTIVE IMMUNOTHERAPEUTIC STRATEGIES USING PEPTIDES
539
IDENTIFICATION OF T AND B CELL EPITOPES
540
RATIONAL DESIGN OF PEPTIDE VACCINES
541
ANTITUMOR IMMUNITY WITH PEPTIDE VACCINES
542
CONCLUSION
542
References
543
72: Peptide Vaccines for Cancer Treatment
545
ABSTRACT
545
USING THE IMMUNE SYSTEM TO TREAT CANCER
545
IDENTIFICATION OF TUMOR ANTIGENS AND PEPTIDES USING ENDOGENOUS IMMUNITY PRESENT IN CANCER PATIENTS
546
COMMON TUMOR ANTIGENS AND ANTIGENIC PEPTIDES RECOGNIZED BY T CELLS
546
FEATURES OF TUMOR-SPECIFIC T CELLS
548
CLINICAL TRIALS OF PEPTIDE BASED CANCER VACCINES
548
STRATEGIES FOR ENHANCING THE EFFICACY OF PEPTIDE-BASED VACCINES
549
CONCLUSION
550
Acknowledgments
550
References
550
73: Antiadhesin Synthetic Peptide Consensus Sequence Vaccine and Antibody Therapeutic for Pseudomonas Aeruginosa
553
ABSTRACT
553
DISEASE TARGET
553
BACKGROUND AND AVAILABLE THERAPIES
553
WHY PEPTIDES
554
CONTRIBUTIONS
556
FUTURE OUTLOOK
559
CONCLUSION
559
References
560
74: Peptide Vaccines for Malaria
561
ABSTRACT
561
INTRODUCTION
561
MALARIAL VACCINES
562
MAIN MALARIAL ANTIGENS INVOLVED IN TARGET CELL BINDING
563
VACCINE DESIGN BASED ON A STRUCTURAL-FUNCTION RELATIONSHIP
564
DESIGN BASED ON THE MHC-PEPTIDE-TCR COMPLEX CONFORMATION
566
DESIGN BASED ON STRUCTURALLY MODIFIED ANTIGEN BINDING TO HLADRb1* MOLECULES
567
DESIGN BASED ON MALARIAL ANTIGENS’ STRUCTURAL MODIFICATION BY INTRODUCING PEPTIDE BOND ISOSTERS
568
CONCLUSION
570
Acknowledgments
570
References
570
75: Peptide Vaccine for Otitis Media
573
ABSTRACT
573
DISEASE TARGET
573
BACKGROUND OF AVAILABLE THERAPIES
573
WHY PEPTIDES?
574
OUR CONTRIBUTIONS TO THE AREA
577
FUTURE OUTLOOK
578
References
578
76: Peptide Vaccine for Alzheimer’s Disease
581
ABSTRACT
581
INTRODUCTION
581
IN VITRO MODULATION OF b-AMYLOID FORMATION
581
EFRH PHAGE ELICITS ANTIBODIES AGAINST b-AMYLOID PEPTIDE
582
PEPTIDES AS VACCINES FOR PREVENTION AND/OR REDUCTION OF AMYLOID PLAQUES IN AD TRANSGENIC MICE
583
ACTIVE IMMUNIZATION OF hAPP TRANSGENIC MICE WITH EFRH-PHAGE AS PEPTIDE VACCINE
584
FUTURE OUTLOOK
585
Acknowledgments
585
References
585
77: Peptide Dendrimers as Immunogens
587
ABSTRACT
587
INTRODUCTION
587
BACKGROUND AND DISCOVERY
587
DESIGN OF PEPTIDE DENDRIMERS AS IMMUNOGENS
588
IMMUNOLOGICAL PROPERTY OF MAPs
589
CELL-MEDIATED RESPONSES INDUCED BY LIPIDATED MAPs
589
REASONS FOR INCREASED IMMUNOGENICITY
590
SYNTHESIS
590
CONTRIBUTION AND FUTURE OUTLOOK
591
References
592
IX: Immunological and Inflammatory Peptides Section
593
78: Chemotactic Peptide Ligands for Formylpeptide Receptors Influencing Inflammation
593
ABSTRACT
593
BACKGROUND
593
FORMYLPEPTIDE RECEPTORS
593
AGONIST PEPTIDES OF FPRs
594
MAMMALIAN PEPTIDES
595
PERSPECTIVES
597
Acknowledgments
597
References
597
79: Complement-Derived Inflammatory Peptides: Anaphylatoxins
599
ABSTRACT
599
HISTORICAL PERSPECTIVE AND SCOPE
599
PRECURSOR mRNA/GENE STRUCTURE, EXPRESSION, AND REGULATION OF ANAPHYLATOXINS
599
GENERATION OF C3a AND C5a ANAPHYLATOXINS
600
STRUCTURE OF ANAPHYLATOXINS
601
RECEPTORS FOR ANAPHYLATOXINS
602
BIOLOGICAL ACTIONS OF ANAPHYLATOXINS
602
PATHOPHYSIOLOGICAL IMPLICATIONS OF ANAPHYLATOXINS
603
Acknowledgment
603
References
603
80: Chemokines: A New Peptide Family of Neuromodulators
605
ABSTRACT
605
DISCOVERY
606
STRUCTURE OF THE PRECURSOR mRNA/GENE
606
DISTRIBUTION OF SDF-1 mRNA AND PROTEIN
606
PROCESSING OF THE PRECURSOR
608
RECEPTORS AND SIGNALING CASCADES
608
RECEPTOR EXPRESSION AND DISTRIBUTION
608
CONFORMATION
609
BIOLOGICAL ACTIONS
609
PATHOPHYSIOLOGICAL IMPLICATIONS
610
References
610
81: Immune Peptides Related to Dipeptidyl Aminopeptidase IV/CD26
613
ABSTRACT
613
INTRODUCTION
613
DP IV/CD26 IN THE IMMUNE SYSTEM
613
DP IV EFFECTOR PEPTIDES
614
PRIMARY DP IV EFFECTOR PEPTIDES
615
SECONDARY IMMUNORELEVANT DP IV PEPTIDE SUBSTRATES
616
PEPTIDE INHIBITORS OF DP IV
617
References
617
82: RGD-Peptides and Some Immunological Problems
619
ABSTRACT
619
DISCOVERY OF THE ANTIADHESIVE RGD-PEPTIDES
619
RGD-PEPTIDES IN PLATELET AGGREGATION
620
BIOLOGICALLY ACTIVE CONFORMATION OF RGD-PEPTIDES
621
RGD PEPTIDES IN IMMUNOLOGICAL PHENOMENA
621
RGD-PEPTIDES AND PATHOGEN INVASIONS
622
RGD-PEPTIDES IN OTHER PATHOLOGICAL PHENOMENA
622
RGD RETROSEQUENCES IN PROTEINS
623
References
623
83: Neuropeptides That Regulate Immune Responses
625
ABSTRACT
625
Acknowledgment
628
References
628
84: Peptides as Targets of T Cell-Mediated Immune Responses
631
ABSTRACT
631
INTRODUCTION
631
MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I AND CLASS II MOLECULES
632
CHARACTERISTICS OF PEPTIDES PRESENTED BY MHC-CLASS I
633
CHARACTERISTICS OF PEPTIDES PRESENTED BY MHC-CLASS II
634
BIOLOGICAL ROLES OF MHC-BOUND PEPTIDES
635
AUTOIMMUNE DISEASES
636
THERAPEUTIC USE OF PEPTIDES
637
CONCLUSION
638
References
638
85: The Use of Positional Scanning Synthetic Peptide Combinatorial Libraries to Identify Immunological Relevant Peptides
641
ABSTRACT
641
DEFINITION OF POSITIONAL SCANNING SYNTHETIC COMBINATORIAL PEPTIDE LIBRARIES (PS-SCL)
641
USE OF PS-SCL TO DETERMINE ANTIBODY LIGANDS
642
USE OF PS-SCL FOR T CELL EPITOPE MAPPING
644
USE OF PS-SCL TO IDENTIFY MHC BINDING MOTIFS
645
CONCLUSION
646
References
646
86: Copolymer 1 and Related Peptides as Immunomodulating Agents
649
ABSTRACT
649
INTRODUCTION
649
SUPPRESSION OF EAE BY GA
650
OTHER PEPTIDES RELATED TO MS
650
CLINICAL TRIALS WITH COPOLYMER 1
651
MECHANISM OF ACTION OF GLATIRAMER ACETATE
651
IN SITU IMMUNOMODULATION AND NEUROGENRATION IN THE CNS
652
POTENTIAL OF GA FOR THE SUPPRESSION OF OTHER AUTOIMMUNE DISORDERS—STUDIES ON INFLAMMATORY BOWEL DISEASES
653
EFFECT OF COPOLYMER 1 ON GRAFT REJECTION
653
CONCLUSION
654
References
654
87: CLIP—A Multifunctional MHC Class II–Associated Self-Peptide
657
ABSTRACT
657
INTRODUCTION
657
THE CLIP RECEPTORS: MHC CLASS II MOLECULES
657
PROTEOLYSIS OF II AND GENERATION OF CLIP
660
FLANKING RESIDUES AND SELF-RELEASE OF CLIP
661
A CHAPERONE FACILITATING CLIP RELEASE: HLA-DM/H2-DM
661
MEMBRANE MICRODOMAINS
662
CLIP AS AN ANTAGONIST OF TH1 POLARIZATION
663
CONCLUSION
664
References
665
X: Brain Peptides Section
667
88: Vasopressin and Oxytocin
667
ABSTRACT
667
DISCOVERY
667
STRUCTURE OF THE PRECURSOR mRNA/GENE
668
DISTRIBUTION OF THE mRNA
669
PROCESSING OF THE PRECURSOR
670
RECEPTORS
671
ACTIVE AND/OR SOLUTION CONFORMATION
672
BIOLOGICAL ACTIONS WITHIN THE BRAIN AND PITUITARY
672
PATHOPHYSIOLOGICAL IMPLICATIONS
672
References
673
89: Thyrotrophin-Releasing Hormone: New Functions for an Ancient Peptide
675
ABSTRACT
675
DISCOVERY OF TRH
675
STRUCTURE OF THE PRECURSOR mRNA/GENE
675
DISTRIBUTION OF PRE-PROTRH mRNA AND PRE-PRO-TRH-DERIVED PEPTIDES
676
PROCESSING OF THE TRH PRECURSOR
676
DISTRIBUTION OF TRH RECEPTORS AND THE TRH DEGRADING ENZYME
676
TRH RECEPTOR SIGNALING CASCADES
677
BIOLOGICAL ACTIONS OF TRH WITHIN THE BRAIN AND PITUITARY
677
PATHOPHYSIOLOGICAL IMPLICATIONS
679
References
679
90: Gonadotrophin Releasing Hormone
681
ABSTRACT
681
DISCOVERY AND BACKGROUND
681
STRUCTURE OF GnRHS AND THEIR PRECURSORS
681
GnRH DISTRIBUTION
683
PROCESSING OF THE GnRH PRECURSOR
684
GnRH RECEPTORS AND SIGNALLING CASCADES
684
PHYSICAL STRUCTURE OF GnRH
688
BIOLOGICAL ACTIONS
688
PATHOPHYSIOLOGY
689
References
690
91: Brain Somatostatin-Related Peptides
691
ABSTRACT
691
DISCOVERY
691
STRUCTURE OF THE PRECURSOR mRNA/GENE
691
DISTRIBUTION OF THE mRNAs AND PEPTIDES
692
PROCESSING OF THE PRECURSORS AND DEGRADATION OF THE PEPTIDE
694
RECEPTORS AND SIGNALING CASCADES
694
INFORMATION ON ACTIVE AND/OR SOLUTION CONFORMATION
696
BIOLOGICAL ACTIONS WITHIN THE BRAIN AND PITUITARY
697
PATHOPHYSIOLOGICAL IMPLICATIONS
697
References
699
92: Corticotrophin-Releasing Hormone (CRH) Peptide Family
701
ABSTRACT
701
DISCOVERY
701
STRUCTURE OF THE PRECURSOR mRNA/GENE
702
DISTRIBUTION AND EXPRESSION OF mRNA
704
PROCESSING OF PREPROHORMONE
704
RECEPTORS AND BINDING PROTEINS
706
BIOLOGICAL ACTIONS IN THE CENTRAL NERVOUS SYSTEM
706
PATHOPHYSIOLOGICAL IMPLICATIONS
707
References
707
93: Growth Hormone-Releasing Hormone
709
ABSTRACT
709
DISCOVERY OF GHRH
709
STRUCTURE OF THE PRECURSOR mRNA/GENE
709
EXPRESSION OF GHRH IN THE BRAIN
710
PROCESSING OF GHRH PRECURSOR
711
GHRH RECEPTOR
711
GHRH SIGNALING
713
CONFORMATION OF GHRH AND SYNTHESIS OF ANALOGS
714
BIOLOGICAL ACTIVITY OF GHRH
714
PATHOPHYSIOLOGICAL IMPLICATIONS
715
References
715
94: PACAP/VIP
719
ABSTRACT
719
DISCOVERY
719
STRUCTURE OF THE PRECURSOR mRNA/GENE
719
DISTRIBUTION OF THE mRNA
720
PROCESSING OF THE PRECURSOR
720
RECEPTORS AND SIGNALING CASCADES
722
SOLUTION STRUCTURE COMPARISON
723
BIOLOGICAL ACTIONS IN THE BRAIN AND THE PITUITARY
723
PATHOPHYSIOLOGY OF PACAP/VIP
725
References
726
95: Neuropeptide Y
729
ABSTRACT
729
DISCOVERY OF NPY AND HOMOLOGS
729
STRUCTURE OF THE PRECURSOR mRNA/GENE
729
PROCESSING OF THE NPY PRECURSOR
731
DISTRIBUTION OF NPY mRNA AND PROTEIN
731
STRUCTURE OF NPY-LIKE PEPTIDES
732
RECEPTORS AND SIGNALING CASCADES
732
BIOLOGICAL ACTIONS
732
PATHOPHYSIOLOGICAL IMPLICATIONS
733
Acknowledgment
733
References
733
96: Melanocortins
735
ABSTRACT
735
DISCOVERY
735
STRUCTURE OF THE PROOPIOMELANOCORTIN mRNA/GENE
735
DISTRIBUTION OF POMC mRNA AND MELANOCORTINS IN THE BRAIN
736
PROCESSING OF PROOPIOMELANOCORTIN
737
CONTROL OF BIOSYNTHESIS AND RELEASE OF BRAIN MELANOCORTINS
738
MELANOCORTIN RECEPTOR FAMILY
738
STRUCTURE–ACTIVITY RELATIONSHIPS FOR MELANOCORTINS
738
BIOLOGICAL ACTIONS WITHIN THE BRAIN
739
PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS
741
References
741
97: Cocaine- and Amphetamine-Regulated Transcript (CART)
743
ABSTRACT
743
DISCOVERY
743
STRUCTURE OF THE PRECURSOR mRNA/GENE
743
PROCESSING OF CART PEPTIDES
743
DISTRIBUTION OF CART mRNA AND PEPTIDES
744
RECEPTORS AND SIGNALING CASCADES
745
BIOLOGICAL ACTIONS OF CART PEPTIDES WITHIN THE BRAIN AND PITUITARY
745
PHYSIOPATHOLOGICAL IMPLICATIONS
747
References
747
98: The Melanin-Concentrating Hormone
751
ABSTRACT
751
DISCOVERY
751
STRUCTURE OF THE PRECURSOR mRNA/GENE
752
DISTRIBUTION OF THE mRNA/PEPTIDES
754
PROCESSING OF THE MCH PRECURSOR
755
RECEPTORS AND SIGNALING CASCADES
755
ACTIVE STRUCTURE OF THE MCH PEPTIDE AND RECEPTOR CONFORMATION
757
BIOLOGICAL ACTIONS OF PRO-MCH-DERIVED PEPTIDES
757
PATHOPHYSIOLOGICAL IMPLICATIONS
758
References
759
99: CCK/Gastrin
761
ABSTRACT
761
DISCOVERY
761
STRUCTURE OF THE PRECURSOR mRNA/GENE
761
DISTRIBUTION OF CCK
761
PROCESSING OF THE PRECURSOR
762
RECEPTORS AND SIGNALING CASCADES
763
ACTIVE AND/OR SOLUTION CONFORMATION
764
BIOLOGICAL ACTIONS WITHIN THE BRAIN AND PITUITARY
764
PATHOPHYSIOLOGICAL IMPLICATIONS
765
References
765
100: The Hypocretins (Orexins)
767
ABSTRACT
767
DISCOVERY
767
STRUCTURE OF THE PRECURSOR mRNA/GENE
767
DISTRIBUTION OF THE mRNA
768
PROCESSING OF THE PRECURSOR
769
RECEPTORS AND SIGNALING CASCADES
769
INFORMATION ON ACTIVE AND/OR SOLUTION CONFORMATION
770
BIOLOGICAL ACTIONS WITHIN THE BRAIN
770
PATHOPHYSIOLOGICAL IMPLICATIONS
772
References
773
101: Ghrelin
777
ABSTRACT
777
DISCOVERY
777
STRUCURE OF THE PRECURSOR AND mRNA/GENE
777
DISTRIBUTION OF GHRELIN mRNA
778
PROCESSING OF THE GHRELIN PRECURSOR
778
RECEPTOR
780
BIOLOGICAL ACTIONS WITHIN THE BRAIN
780
PATHOPHYSIOLOGICAL IMPLICATIONS
780
References
781
102: Neurotensin
783
ABSTRACT
783
DISCOVERY OF NEUROTENSIN
783
STRUCTURE OF THE PRECURSOR mRNA/GENE
783
NT/N mRNA EXPRESSION IN BRAIN
784
PROCESSING OF THE PRECURSOR
784
RECEPTORS AND SIGNALING CASCADES
785
INFORMATION ON ACTIVE OR SOLUTION CONFORMATION
785
BRAIN FUNCTIONS
785
PATHOPHYSIOLOGICAL IMPLICATIONS
787
References
787
103: Neuromedin U (NMU): Brain Peptide
791
ABSTRACT
791
NMU DISCOVERY
791
STRUCTURE OF THE PRECURSOR mRNA/GENE
791
NMU DISTRIBUTION AND PROCESSING
791
NMU RECEPTORS
792
NMU1R
793
NMU2R
793
BIOLOGICAL ACTIONS OF NMU IN THE BRAIN
794
PATHOPHYSIOLOGICAL IMPLICATIONS
796
References
796
104: Galanin and GALP Systems in Brain—Molecular Pharmacology, Anatomy, and Putative Roles in Physiology and Pathology
799
ABSTRACT
799
DISCOVERY OF GALANIN AND GALANINLIKE PEPTIDE (GALP)
799
STRUCTURE AND REGULATION OF THE GALANIN AND GALP GENES
799
DISTRIBUTION OF GALANIN AND GALP mRNA AND PEPTIDE-IMMUNOREACTIVITY
800
NATURE AND PROCESSING OF GALANIN AND GALP PRECURSORS
800
GALANIN FAMILY RECEPTORS
801
CENTRAL ACTIONS OF GALANIN AND GALP IN NORMAL AND PATHOPHYSIOLOGY
802
References
806
105: Brain Tachykinins
809
ABSTRACT
809
DISCOVERY
809
STRUCTURE OF THE PRECURSOR mRNA/GENE
809
DISTRIBUTION OF THE mRNA
810
PROCESSING OF THE PRECURSOR
812
RECEPTORS AND SIGNALING CASCADES
813
ACTIVE AND SOLUTION CONFORMATION
813
BIOLOGICAL ACTIONS WITHIN THE BRAIN
814
PATHOPHYSIOLOGICAL IMPLICATIONS
815
References
815
106: CGRP and Adrenomedullin in the Brain
817
ABSTRACT
817
DISCOVERY
817
STRUCTURE OF THE PRECURSOR mRNA/GENE
817
DISTRIBUTION OF THE mRNA/PEPTIDE
819
CGRP
819
PROCESSING OF THE PRECURSOR
820
RECEPTORS AND SIGNALING CASCADES
821
PEPTIDE CONFORMATION
822
BIOLOGICAL ACTIONS WITHIN THE BRAIN
822
CGRP
822
PATHOLOGICAL IMPLICATIONS
823
Acknowledgments
823
References
823
107: The RFamide-Related Peptides
825
ABSTRACT
825
DISCOVERY OF THE MAMMALIAN RFAMIDERELATED PEPTIDES
825
STRUCTURE OF THE RFAMIDE-RELATED PEPTIDE PRECURSORS
825
PROCESSING OF THE RFAMIDE-RELATED PEPTIDE PRECURSORS
827
DISTRIBUTION OF RFAMIDE-RELATED PEPTIDES IN THE BRAIN
827
RFAMIDE-RELATED PEPTIDE RECEPTORS
829
INFORMATION ON SOLUTION CONFORMATION OF RFAMIDERELATED PEPTIDES
829
BIOLOGICAL ACTIONS OF RFAMIDERELATED PEPTIDES WITHIN THE BRAIN AND PITUITARY
829
References
830
108: Apelin: Discovery, Distribution, and Physiological Role
833
ABSTRACT
833
DISCOVERY
833
STRUCTURE OF THE PRECURSOR mRNA/GENE AND PROCESSING OF THE PRECURSOR
834
RECEPTORS AND SIGNALING CASCADES
834
DISTRIBUTION OF APELIN AND ITS RECEPTOR IN THE RAT BRAIN
835
BIOLOGICAL ACTIONS WITHIN THE BRAIN AND PITUITARY GLAND
835
PERIPHERAL CARDIOVASCULAR ACTIONS
838
CONCLUSION
838
Acknowledgments
838
References
838
109: Urotensin II and Urotensin II–Related Peptide
841
ABSTRACT
841
DISCOVERY
841
STRUCTURE
841
LOCALIZATION
842
RECEPTORS AND SIGNALING CASCADES
845
BIOLOGICAL ACTIONS WITHIN THE BRAIN
845
PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL SIGNIFICANCE
846
References
846
110: Brain/B-Type Natriuretic Peptide (BNP) and C-Type Natriuretic Peptide (CNP)
851
ABSTRACT
851
DISCOVERY
851
STRUCTURE OF THE PRECURSOR mRNA AND GENE
853
DISTRIBUTION OF mRNA
853
PROCESSING OF PRECURSOR
855
RECEPTORS AND SIGNALING CASCADE
855
BIOLOGICAL ACTIONS IN THE BRAIN
856
PATHOPHYSIOLOGICAL IMPLICATIONS
856
References
857
111: Endozepines
859
ABSTRACT
859
DISCOVERY
859
STRUCTURE OF THE PRECURSOR mRNA/GENE
859
DISTRIBUTION OF DBI mRNA AND ENDOZEPINE IMMUNOREACTIVITY
859
PROCESSING OF DBI
861
RECEPTORS AND SIGNALING CASCADES
861
CONTROL OF BIOSYNTHESIS AND RELEASE OF ENDOZEPINES
862
INFORMATION ON SOLUTION CONFORMATION OF ENDOZEPINES
862
BIOLOGICAL ACTIONS OF ENDOZEPINES WITHIN THE BRAIN
863
PATHOPHYSIOLOGICAL IMPLICATIONS
863
References
864
112: KiSS-1/Metastin
867
ABSTRACT
867
DISCOVERY OF KiSS-1 SYSTEM
867
STRUCTURE OF THE KiSS-1 GENE
868
PROCESSING OF KiSS-1 PRECURSOR: THE KISSPEPTINS
868
DISTRIBUTION OF KiSS-1 mRNA/PROTEIN WITHIN THE BRAIN
868
GPR54 AS RECEPTOR FOR KISSPEPTINS: STRUCTURE AND SIGNALING CASCADES
870
BIOLOGICAL ACTIONS OF KiSSPEPTINS: BRAIN AND PITUITARY EFFECTS
870
PATHOPHYSIOLOGICAL IMPLICATIONS
872
Acknowledgments
873
References
873
XI: Endocrine Peptides Section
875
113: Role of Opioid Peptides in the Local Regulation of Endocrine Glands
875
ABSTRACT
875
INTRODUCTION
875
PITUITARY GLAND
875
PANCREATIC ISLETS
876
ADRENAL GLAND
876
CONCLUSION
877
References
877
114: Role of Tachykinin-Gene-Related Peptides in the Local Regulation of Endocrine Glands
879
ABSTRACT
879
INTRODUCTION
879
PITUITARY GLAND
879
THYROID GLAND
880
PARATHYROID GLAND
880
PANCREATIC ISLETS
880
ADRENAL GLAND
881
LEYDIG CELLS
881
OVARY
882
CONCLUSION
882
References
882
115: Neuropeptide Y and the Regulation of Endocrine Function
885
ABSTRACT
885
INTRODUCTION
885
NPY AND ADRENAL FUNCTION
885
NPY IN THE PANCREAS
886
NPY AND GONADAL FUNCTION
887
NPY AND THYROID FUNCTION
888
CONCLUSION
889
References
889
116: Effects of PACAP in the Local Regulation of Endocrine Glands
893
ABSTRACT
893
INTRODUCTION
893
EFFECTS ON THE PITUITARY GLAND
893
EFFECTS ON THE THYROID GLAND
895
EFFECTS OF PACAP ON THE ENDOCRINE TESTIS AND OVARY
895
EFFECTS OF PACAP ON THE ADRENAL
895
EFFECTS OF PACAP ON PANCREATIC ISLETS
896
References
897
117: Endothelins in the Local Regulation of Endocrine Glands
901
ABSTRACT
901
INTRODUCTION
901
PITUITARY GLAND
901
THYROID GLAND
902
PARATHYROID GLAND
902
PANCREATIC ISLETS
903
ADRENAL GLAND
903
LEYDIG CELLS
904
OVARY
904
CONCLUSION
905
References
905
118: Adrenomedullin and Related Peptides in the Local Regulation of Endocrine Glands
907
ABSTRACT
907
INTRODUCTION
907
PITUITARY
907
ADRENALS
908
ENDOCRINE PANCREAS
909
DIFFUSE ENDOCRINE SYSTEM OF THE GUT
910
OTHER ENDOCRINE ORGANS
910
CONCLUSION
911
Acknowledgments
911
References
911
119: Ghrelin in the Local Regulation of Endocrine Glands
915
ABSTRACT
915
INTRODUCTION
915
GHRELIN AND THE PITUITARY
915
GHRELIN AND THE THYROID
916
GHRELIN AND THE HEART AND CARDIOMYOCYTES
916
GHRELIN—A NOVEL PEPTIDE FOR CARTILAGE AND BONE HOMEOSTASIS
917
GHRELIN AND THE PANCREAS
917
GHRELIN AND THE ADRENAL CORTEX
918
GHRELIN AND THE REPRODUCTIVE SYSTEM
918
CONCLUSION
919
Acknowledgments
919
References
919
120: Atrial Natriuretic Peptide in Local Regulation of Endocrine Glands
923
ABSTRACT
923
DISCOVERY
923
STRUCTURE OF THE PRECURSOR mRNA GENE
923
DISTRIBUTION OF ANP mRNA
924
PROCESSING
924
RELEASE OF NPs
925
RECEPTORS AND SIGNALING CASCADE
925
BIOLOGICAL ACTIVITIES OF NPs
925
PATHOPHYSIOLOGICAL IMPLICATIONS
927
References
927
121: Galanin, Neurotensin, and Neuromedins in the Local Regulation of Endocrine Glands
929
ABSTRACT
929
INTRODUCTION
929
GALANIN
929
NEUROTENSIN
931
NEUROMEDINS
932
CONCLUSION
932
References
933
XII: Ingestive Peptides Section
935
122: Neuropeptide Y: A Conductor of the Appetite-Regulating Orchestra in the Hypothalamus
935
ABSTRACT
935
INTRODUCTION
935
NPY AND APPETITE
935
MECHANISM OF ACTION
936
REGULATION OF NPY SIGNALING AND APPETITE
937
PATHOPHYSIOLOGY
938
Acknowledgment
939
References
939
123: Hypothalamic Galanin and Ingestive Behavior: Relation to Dietary Fat, Alcohol, and Circulating Lipids
941
ABSTRACT
941
STIMULATORY EFFECTS OF GAL INJECTION ON INGESTIVE BEHAVIOR
941
EFFECTS PRODUCED BY MUTATIONS OF THE GAL GENE OR GAL RECEPTOR GENES
942
EFFECTS OF CIRCULATING HORMONES AND DIETARY CONDITIONS ON ENDOGENOUS GAL
942
SITES OF ACTION AND NEURAL NETWORKS AFFECTED
943
RECEPTORS AND SIGNALING PATHWAYS MEDIATING GAL EFFECTS ON INGESTIVE BEHAVIOR
944
GAL IN RELATION TO OTHER PEPTIDERGIC AND AMINERGIC SYSTEMS CONTROLLING INGESTIVE BEHAVIOR
944
PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL CONSEQUENCES OF GAL’S ACTIONS
944
Acknowledgments
945
References
945
124: Effects of Melanocortins on Ingestive Behavior
949
ABSTRACT
949
EFFECTS OF THE MELANOCORTINS ON FEEDING BEHAVIOR
949
GENETIC STUDIES ON MELANOCORTIN ACTION
950
FUNCTIONAL RESPONSE OF THE MELANOCORTINS TO DIFFERING METABOLIC AND FEEDING STATES
951
NEUROANATOMY OF THE CENTRAL MELANOCORTIN SYSTEM
953
RECEPTORS AND SIGNALING PATHWAYS RESPONSIBLE FOR MELANOCORTIN ACTIONS ON INGESTIVE BEHAVIOR
954
INTERACTIONS OF THE MELANOCORTINS WITH OTHER PEPTIDERGIC/AMINERGIC SYSTEMS
955
PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS
955
References
956
125: CART Peptide and Ingestive Behavior
959
ABSTRACT
959
DESCRIPTION OF CART PEPTIDE EFFECTS ON FEEDING BEHAVIOR
959
STUDIES FROM GENETIC MANIPULATIONS OR MUTATIONS
959
FUNCTIONAL RESPONSE OF CART TO DIFFERING METABOLIC AND FEEDING STATES
960
SITES OF ACTION AND NEURAL NETWORKS AFFECTED
960
RECEPTORS AND SIGNALING PATHWAYS RESPONSIBLE FOR INGESTIVE BEHAVIORS
961
INTERACTIONS WITH OTHER PEPTIDERGIC/AMINERGIC SYSTEMS
961
PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS
962
References
962
126: Orexins and Opioids in Feeding Behavior
965
ABSTRACT
965
EFFECT OF OREXINS AND OPIOIDS ON FEEDING BEHAVIOR
965
STUDIES FROM GENETIC MANIPULATIONS OR MUTATIONS
967
FUNCTIONAL RESPONSE OF OREXINS AND OPIOIDS TO METABOLIC AND FEEDING STATES
967
OxA AND OPIOID LIGANDS AND RECEPTORS: SITES OF ACTION AND NEURAL NETWORKS AFFECTED
968
INTERACTIONS WITH OTHER PEPTIDERGIC/AMINERGIC SYSTEMS
969
PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS
969
INTERACTION BETWEEN OxA AND OPIOIDS
970
CONCLUSION
970
References
970
127: Melanin-Concentrating Hormone
975
ABSTRACT
975
INTRODUCTION
975
EFFECTS OF MCH ON FEEDING BEHAVIOR
975
STUDIES FROM GENETIC MANIPULATIONS OR MUTATIONS
976
FUNCTIONAL RESPONSE OF THE PEPTIDE/GENE TO DIFFERING METABOLIC AND FEEDING STATES
976
SITES OF ACTION AND NEURAL NETWORKS AFFECTED
977
RECEPTORS AND SIGNALING PATHWAYS RESPONSIBLE FOR THE INGESTIVE EFFECTS
978
INTERACTIONS WITH OTHER PEPTIDERGIC/AMINERGIC SYSTEMS
978
PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS
978
References
979
128: Corticotrophin-Releasing Hormone (CRH) and Ingestive Behavior
983
ABSTRACT
983
EFFECTS OF CRH AND UROCORTINS ON FEEDING BEHAVIOR
983
STUDIES FROM GENETIC MANIPULATIONS
984
METABOLIC REGULATION OF CRH AND CRH RECEPTORS
984
SITES OF ACTION AND NETWORKS MEDIATING CRH EFFECTS
984
RECEPTORS AND PATHWAYS MEDIATING THE EFFECTS OF CRH AND THE UROCORTINS ON FOOD INTAKE
985
INTERACTIONS WITH NEUROPEPTIDE SYSTEMS
985
PHYSIOLOGY AND PATHOPHYSIOLOGICAL IMPLICATIONS
986
References
986
129: Peptide YY (PYY) and Neuromedin U (NMU): Effects on Ingestive Behavior
991
ABSTRACT
991
INTRODUCTION
991
DISCOVERY
992
DISTRIBUTION AND RELEASE
992
RECEPTORS
992
THE ROLE OF NMU IN THE REGULATION OF ENERGY BALANCE
993
PYY
994
CONCLUSION
995
References
995
130: Ghrelin and Ingestive Behavior
999
ABSTRACT
999
GHRELIN ADMINISTRATION INDUCES FOOD INTAKE ACROSS SPECIES
999
THE GROWTH HORMONE SECRETAGOGUE RECEPTOR GHSR-1a MEDIATES GHRELIN-INDUCED FOOD INTAKE
1000
GHRELIN TARGETS THE HYPOTHALAMUS TO INCREASE FOOD INTAKE AND BODY WEIGHT
1000
OTHER HYPOTHALAMIC PATHWAYS INVOLVED IN GHRELIN-INDUCED HYPERPHAGIA
1001
EXTRA-HYPOTHALAMIC EFFECTS OF GHRELIN ON FOOD INTAKE
1002
PERIPHERAL GHRELIN LEVELS ARE REGULATED BY FOOD INTAKE
1002
References
1004
131: Cholecystokinin and Satiety
1007
ABSTRACT
1007
INTRODUCTION
1007
FEEDING ACTIONS OF PERIPHERAL CCK
1007
FEEDING ACTIONS OF CENTRAL CCK
1009
STUDIES WITH OLETF RATS AND CCK-A RECEPTOR KNOCKOUT MICE
1009
FUNCTIONAL RESPONSES TO PERIPHERAL CCK IN DIFFERING METABOLIC STATES
1010
SITES OF ACTION FOR PERIPHERAL CCK IN SATIETY
1011
RECEPTORS AND SIGNALING PATHWAYS MEDIATING CCK SATIETY
1011
INTERACTIONS WITH OTHER SIGNALING SYSTEMS
1012
PATHOPHYSIOLOGIAL IMPLICATIONS
1012
References
1012
132: Enterostatin, a Peptide Regulator of Dietary Fat Ingestion
1015
ABSTRACT
1015
INTRODUCTION
1015
ENTEROSTATIN EFFECTS ON FEEDING BEHAVIOR
1015
GENOMIC STUDIES
1016
FUNCTIONAL RESPONSES TO DIFFERING FEEDING AND METABOLIC CONDITIONS
1016
SITES OF ACTION AND NEURAL NETWORKS AFFECTED
1017
RECEPTORS AND SIGNALING PATHWAYS
1018
PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS
1019
References
1019
133: Regulation of Feeding Behavior by Glucagonlike Peptide 1 (GLP-1)
1021
ABSTRACT
1021
EFFECTS OF GLP-1 ON FEEDING BEHAVIOR
1021
STUDIES FROM GENETIC MANIPULATIONS (KNOCKOUTS, TRANSGENICS) AND SYNTHETIC ANALOGS
1021
FUNCTIONAL RESPONSE OF THE GLP-1 PEPTIDE/GENE TO DIFFERING METABOLIC AND FEEDING STATES
1022
SITES OF ACTION AND NEURAL NETWORKS AFFECTED BY GLP-1
1022
GLP-1 RECEPTORS AND SIGNALING PATHWAYS RESPONSIBLE FOR THE INGESTIVE EFFECTS
1022
INTERACTIONS OF GLP-1 WITH OTHER PEPTIDERGIC/AMINERGIC SYSTEMS
1023
PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS
1023
References
1024
134: Role of Amylin and Calcitonin-Gene-Related Peptide (CGRP) in the Control of Food Intake
1027
ABSTRACT
1027
INTRODUCTION
1027
CHARACTERIZATION OF THE EFFECTS OF AMYLIN AND CGRP ON FOOD INTAKE
1027
FOOD INTAKE IN KNOCKOUT ANIMALS
1028
FOOD INTAKE IN ANIMALS OVEREXPRESSING AMYLIN
1029
FOOD INTAKE IN ANIMALS DEFICIENT OF CGRP OR OVEREXPRESSING CGRP
1029
REGULATION OF AMYLIN AND CGRP SYNTHESIS AND SECRETION
1029
CENTRAL PATHWAYS MEDIATING THE ANORECTIC EFFECTS OF AMYLIN AND CGRP
1029
HYPOTHALAMIC INVOLVEMENT IN THE ANORECTIC ACTION OF PERIPHERAL AMYLIN
1030
RECEPTORS AND SIGNALING PATHWAYS
1030
INTERACTION WITH OTHER PEPTIDES REGULATING INGESTIVE BEHAVIOR
1031
INTERACTION BETWEEN AMYLIN AND METABOLITES
1031
PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS
1031
CONCLUSION
1031
References
1031
135: Leptin and the Regulation of Feeding
1033
ABSTRACT
1033
LEPTIN AND FEEDING BEHAVIOR
1033
THE ABSENCE OF LEPTIN ACTION
1033
FUNCTIONAL RESPONSES TO LEPTIN DURING ALTERED METABOLIC STATES
1034
SITES OF LEPTIN ACTION
1034
LEPTIN RECEPTORS AND INTRACELLULAR SIGNALING PATHWAYS
1034
PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS
1036
References
1037
136: Ingestive Peptides: Insulin
1039
ABSTRACT
1039
INTRODUCTION
1039
EFFECTS OF INSULIN ON FEEDING BEHAVIOR
1039
GENETIC AND MOLECULAR BIOLOGICAL MANIPULATIONS
1041
METABOLIC STATES
1041
SITE OF ACTION AND NEURAL NETWORKS AFFECTED
1042
RECEPTORS AND SIGNALING PATHWAYS
1042
PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS
1042
CONCLUSION
1043
References
1043
XIII: Gastrointestinal Peptides Section
1045
137: Adrenomedullin in Gastrointestinal Function
1045
ABSTRACT
1045
INTRODUCTION
1045
STRUCTURE
1045
EXPRESSION AND DISTRIBUTION
1046
RELEASE
1046
RECEPTORS AND SIGNAL TRANSDUCTION PATHWAYS
1046
BIOLOGICAL ACTIONS
1047
CONCLUSION
1048
Acknowledgment
1048
References
1048
138: Calcitonin Gene-Related Peptide and Gastrointestinal Function
1051
ABSTRACT
1051
INTRODUCTION
1051
DISTRIBUTION OF CGRP IN THE GI TRACT
1051
CGRP RECEPTORS IN THE GI TRACT
1052
RELEASE OF CGRP IN THE GI TRACT
1053
PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS OF CGRP IN THE GI TRACT
1053
References
1056
139: Peripheral Cholecystokinin
1059
ABSTRACT
1059
DISCOVERY
1059
STRUCTURE OF THE PRECURSOR mRNA/GENE
1060
CHOLECYSTOKININ PEPTIDE DISTRIBUTION
1060
PROCESSING OF PREPROCHOLECYSTOKININ
1060
MOLECULAR FORMS OF CHOLECYSTOKININ
1062
CHOLECYSTOKININ RECEPTORS
1062
SOLUTION CONFORMATION
1063
PERIPHERAL BIOLOGICAL ACTIONS OF CHOLECYSTOKININ
1064
CONCLUSION
1066
References
1066
140: Corticotrophin-Releasing Hormone (CRH) Family in the Gastrointestinal System
1069
ABSTRACT
1069
INTRODUCTION
1069
EXPRESSION AND LOCATION OF CRH PEPTIDES AND RECEPTORS IN THE GI SYSTEM
1069
ACTIONS OF CRH AND RELATED PEPTIDES IN GI FUNCTIONS
1070
NEURONAL PATHWAYS INVOLVED IN CRH ACTIONS IN GI FUNCTIONS
1072
PATHOPHYSIOLOGICAL IMPLICATIONS
1072
Acknowledgment
1073
References
1073
141: Paneth Cell a-Defensins
1075
ABSTRACT
1075
DISCOVERY OF ENTERIC PANETH CELL a-DEFENSINS
1075
a-DEFENSIN GENE AND PRECURSOR STRUCTURES
1076
DISTRIBUTION OF a-DEFENSINS IN THE GASTROINTESTINAL TRACT
1078
STRUCTURES OF PANETH CELL a-DEFENSINS
1078
MECHANISMS OF ACTION
1078
PATHOPHYSIOLOGICAL IMPLICATIONS
1080
Acknowledgments
1080
References
1080
142: Galanin in the Gastrointestinal Tract: Distribution and Function
1083
ABSTRACT
1083
INTRODUCTION
1083
GALANIN DISTRIBUTION
1083
BIOLOGICAL EFFECTS OF GALANIN IN THE GASTROINTESTINAL TRACT
1084
GALANIN RECEPTORS
1084
INFLAMMATION AND INJURY
1087
Acknowledgment
1087
References
1087
143: Gastrin
1089
ABSTRACT
1089
DISCOVERY
1089
STRUCTURE OF THE GENE AND PRECURSOR
1089
DISTRIBUTION OF MRNA IN GUT
1090
RECEPTOR EXPRESSION AND REGULATION
1090
BIOLOGICAL ACTIONS ON GI TRACT
1090
PATHOPHYSIOLOGICAL IMPLICATIONS
1091
References
1091
144: Gastrin-Releasing Peptide
1093
ABSTRACT
1093
INTRODUCTION
1093
STRUCTURE OF THE PRECURSOR mRNA/GENE AND PEPTIDE VARIANTS
1093
DISTRIBUTION OF GRP-LIKE IMMUNOREACTIVITY, GRP mRNA, AND GRP RECEPTOR
1094
RECEPTOR SUBTYPES AND SIGNALING
1095
BIOLOGICAL ACTIONS WITHIN THE GI TRACT
1095
PATHOPHYSIOLOGICAL IMPLICATIONS
1099
References
1100
145: Glucagonlike Peptides 1 and 2, Enteroglucagon, Glicentin, and Oxyntomodulin
1103
ABSTRACT
1103
DISCOVERY AND STRUCTURE OF THE GENE
1103
EXPRESSION OF THE GENE
1104
ACTIVE CONFORMATION AND METABOLISM
1105
RECEPTOR EXPRESSION
1105
BIOLOGICAL ACTIONS
1106
ACTIONS OF GLP-1
1106
PATHOPHYSIOLOGICAL IMPLICATIONS
1109
References
1110
146: Ghrelin
1111
ABSTRACT
1111
ALTERNATIVE DISCOVERIES OF GHRELIN
1111
STRUCTURE OF THE PRECURSOR mRNA/GENE
1111
DISTRIBUTION IN THE GASTROINTESTINAL TRACT
1112
STRUCTURE–ACTIVITY RELATIONS OF GHRELIN AND OF THE GHRELIN RECEPTOR
1112
BIOLOGICAL ACTION ON THE GASTROINTESTINAL TRACT
1113
PATHOPHYSIOLOGICAL IMPLICATIONS AND THERAPEUTIC POTENTIAL
1114
Acknowledgments
1115
References
1115
147: Leptin and the Gastrointestinal Tract
1117
ABSTRACT
1117
INTRODUCTION
1117
THE STOMACH PRODUCES LEPTIN
1117
GASTRIC LEPTIN IS A NEUROENDOCRINE MOLECULE FOR SATIETY
1118
GASTRIC LEPTIN ENTERS THE INTESTINE
1118
LEPTIN REGULATES INTESTINAL ENDOCRINE SECRETIONS
1118
GUT LEPTIN AND INTESTINAL ABSORPTION OF NUTRIENTS
1119
LEPTIN AND GUT PATHOLOGIES
1120
CONCLUSION
1120
Acknowledgments
1121
References
1121
148: Motilin
1123
ABSTRACT
1123
DISCOVERY OF MOTILIN
1123
STRUCTURE OF MOTILIN AND RELATED PEPTIDES
1123
DISTRIBUTION IN THE GI TRACT
1125
STRUCTURE–ACTIVITY
1126
RECEPTOR
1126
BIOLOGICAL ACTIONS
1127
PATHOPHYSIOLOGICAL IMPLICATION
1129
Acknowledgments
1129
References
1130
149: Neurotensin in Regulation of Gastrointestinal Functions
1131
ABSTRACT
1131
INTRODUCTION
1131
NT INHIBITS MOTILITY AND SECRETION IN THE STOMACH AND SMALL INTESTINE
1132
NT ENHANCES COLONIC MOTILITY AND STIMULATES SECRETION
1132
ROLE OF NT AND NTR1 IN INTESTINAL INFLAMMATION
1133
NT PROMOTES CELL GROWTH, REGENERATION, AND HEALING OF THE GI MUCOSA
1133
NT AND COLONIC STRESS RESPONSES
1133
CONCLUSION
1134
References
1134
150: Pituitary Adenylate Cyclase Activating Polypeptide (PACAP)
1137
ABSTRACT
1137
PACAP IS A NEWLY DISCOVERED NEUROENTERIC PEPTIDE
1137
CLONING AND CHARACTERIZATION OF PAC1
1137
SIGNAL TRANSDUCTION OF PAC1
1138
LOCALIZATION OF PAC1
1138
PHYSIOLOGY OF PAC1 IN THE GASTROINTESTINAL TRACT
1139
CONCLUSION
1140
Acknowledgments
1140
References
1140
151: Pancreatic Polypeptide
1143
ABSTRACT
1143
DISCOVERY OF PANCREATIC POLYPEPTIDE AS IT RELATES TO THE GASTROINTESTINAL TRACT
1143
STRUCTURE OF THE PRECURSOR mRNA/GENE AND PEPTIDE VARIANTS
1144
DISTRIBUTION OF THE mRNA AND PROTEIN
1144
RECEPTOR SUBTYPES, SIGNALING, AND DISTRIBUTION
1145
BIOLOGICAL ACTIONS
1147
PHYSIOPATHOLOGICAL IMPLICATIONS
1149
References
1150
152: Peptide YY
1155
ABSTRACT
1155
INTRODUCTION
1155
STRUCTURE OF THE PYY GENE AND PYY BIOSYNTHESIS
1155
GASTROINTESTINAL DISTRIBUTION AND ONTOGENY OF INTESTINAL PYY
1155
REGULATION OF PYY SECRETION
1156
PYY RECEPTORS
1157
BIOLOGICAL ACTIONS ON THE GASTROINTESTINAL TRACT
1158
GROWTH PROMOTING ACTIONS OF PYY ON THE GASTROINTESTINAL TRACT
1159
INHIBITORY ACTION OF PYY(3–36) ON APPETITE AND FOOD INTAKE
1159
PATHOPHYSIOLOGY OF PYY
1159
References
1159
153: Secretin
1161
ABSTRACT
1161
DISCOVERY OF SECRETIN
1161
STRUCTURE OF SECRETIN, ITS PRECURSOR TRANSCRIPT, AND GENE
1161
DISTRIBUTION OF SECRETIN AND ITS mRNA
1162
SECRETIN RECEPTOR SUBTYPES, DISTRIBUTION, AND SIGNALING
1164
BIOLOGICAL ACTIONS OF SECRETIN IN THE GASTROINTESTINAL TRACT
1164
PATHOPHYSIOLOGY AND CLINICAL APPLICATION OF SECRETIN
1167
References
1167
154: Somatostatin
1169
ABSTRACT
1169
INTRODUCTION
1169
SOMATOSTATIN-14, SOMATOSTATIN-28 AND CORTISTATIN IN THE GASTROINTESTINAL TRACT
1169
SOMATOSTATIN RECEPTORS IN THE GASTROINTESTINAL TRACT
1170
BIOLOGICAL ACTION OF SOMATOSTATIN IN THE GASTROINTESTINAL TRACT
1170
SOMATOSTATIN AND SOMATOSTATIN RECEPTORS IN THE DISEASED GASTROINTESTINAL TRACT
1171
SOMATOSTATIN ANALOGS AND THEIR CLINICAL APPLICATIONS IN GASTROINTESTINAL DISEASE
1172
References
1173
155: Somatostatin Analogs in theGastrointestinal Tract
1177
ABSTRACT
1177
INTRODUCTION
1177
GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS
1177
SECRETORY DIARRHEAS
1179
ESOPHAGEAL VARICEAL HEMORRHAGE
1180
GI MOTILITY AND FUNCTIONAL GI DISORDERS
1180
POSTOPERATIVE COMPLICATIONS OF SURGERY
1181
BILIARY SYSTEM
1182
References
1182
156: Substance P and Related Tachykinins in the Gastrointestinal Tract
1185
ABSTRACT
1185
DISCOVERY OF TACHYKININS IN THE GUT
1185
DISTRIBUTION OF TACHYKININ mRNAS AND PEPTIDES IN THE GI TRACT
1185
TACHYKININ RECEPTOR SUBTYPES, SIGNALING, AND DISTRIBUTION IN THE GI TRACT
1186
BIOLOGICAL ACTIONS OF TACHYKININS IN THE GUT
1187
PATHOPHYSIOLOGICAL IMPLICATIONS OF TACHYKININS IN THE GI TRACT
1188
Acknowledgments
1190
References
1191
157: TFF (Trefoil Factor Family) Peptides
1193
ABSTRACT
1193
DISCOVERY
1193
STRUCTURE OF THE PRECURSOR mRNA/GENE
1193
EXPRESSION IN THE GI TRACT
1194
ACTIVE CONFORMATION, 3D STRUCTURE
1196
TFF RECEPTORS AND SIGNALING CASCADES
1196
BIOLOGICAL ACTIONS ON THE GI TRACT
1196
PATHOPHYSIOLOGICAL IMPLICATIONS
1198
Acknowledgments
1199
References
1199
158: Signaling by Vasoactive Intestinal Peptide in Gastrointestinal Smooth Muscle
1201
ABSTRACT
1201
INTRODUCTION
1201
INTERPLAY OF INHIBITORY NEUROTRANSMITTERS
1202
VIP RECEPTORS AND THEIR SIGNALING IN SMOOTH MUSCLE
1202
Acknowledgments
1205
References
1205
XIV: Cardiovascular Peptides Section
1209
159: Adrenomedullin and Its Related Peptides
1209
ABSTRACT
1209
DISCOVERY AND STRUCTURE OF AM
1209
STRUCTURE OF THE PRECURSOR mRNA/GENE
1209
DISTRIBUTION OF THE mRNA AND PEPTIDE IN THE CARDIOVASCULAR SYSTEM
1210
RECEPTORS AND THEIR DISTRIBUTION IN THE CARDIOVASCULAR SYSTEM
1211
BIOLOGICAL ACTIONS IN THE CARDIOVASCULAR SYSTEM
1211
PROADRENOMEDULLIN N-TERMINAL 20 PEPTIDE
1212
INFORMATION ON MOLECULAR FORM OF AM
1213
CLINICAL IMPLICATION OF AM IN CARDIOVASCULAR DISEASES
1213
CONCLUSION
1213
References
1214
160: Angiotensin II and Its Related Peptides
1215
ABSTRACT
1215
DISCOVERY
1215
STRUCTURE OF THE PEPTIDE AND COMPONENT OF RA SYSTEM
1215
DISTRIBUTION OF RA SYSTEM, PROCESSING, AND ENDOGENOUS FORM IN THE CARDIOVASCULAR SYSTEM
1216
RECEPTORS AND THEIR DISTRIBUTION IN THE CARDIOVASCULAR SYSTEM
1216
BIOLOGICAL ACTIONS AND PATHOPHYSIOLOGICAL IMPLICATION IN THE CARDIOVASCULAR SYSTEM
1217
References
1219
161: Bradykinin and Its Related Peptides
1221
ABSTRACT
1221
DISCOVERY
1221
STRUCTURE OF KININOGEN mRNA AND GENE
1221
DISTRIBUTION OF KININOGEN AND KALLIKREIN mRNA AND KININ PEPTIDES
1222
FORMATION OF KININ PEPTIDES
1222
METABOLISM OF KININ PEPTIDES
1223
KININ RECEPTORS AND THEIR DISTRIBUTION IN THE CARDIOVASCULAR SYSTEM
1224
ROLE OF KININ PEPTIDES IN HEALTH AND DISEASE STATES
1224
References
1224
162: Calcitonin Gene-Related Peptides
1227
ABSTRACT
1227
CALCITONIN GENE-RELATED PEPTIDE
1227
Acknowledgments
1230
References
1230
163: Endothelins
1233
ABSTRACT
1233
DISCOVERY
1233
STRUCTURE OF THE PRECURSOR mRNA/GENE AND PROCESSING
1233
PLASMA CONCENTRATION AND INACTIVATION OF ENDOTHELIN 1
1235
RECEPTORS AND THEIR DISTRIBUTION
1236
BIOLOGICAL ACTIONS IN THE CARDIOVASCULAR SYSTEM
1237
References
1238
164: Ghrelin: Its Therapeutic Potential in Heart Failure
1239
ABSTRACT
1239
INTRODUCTION
1239
DISCOVERY, STRUCTURE, AND SYNTHESIS
1240
RECEPTORS AND THEIR DISTRIBUTION
1240
BIOLOGICAL ACTINS
1240
CLINICAL APPLICATION OF GHRELIN
1241
CONCLUSION
1242
References
1242
165: Natriuretic Peptides in the Cardiovascular System
1245
ABSTRACT
1245
DISCOVERY OF NATRIURETIC PEPTIDES
1245
STRUCTURE OF THE PRECURSORS, mRNAs, AND GENES OF NPs
1246
DISTRIBUTION OF THE mRNA AND PEPTIDE IN THE CARDIOVASCULAR SYSTEM
1247
PROCESSING AND ENDOGENOUS FORMS OF NPs
1248
RECEPTORS OF NPs AND THEIR DISTRIBUTION IN THE CARDIOVASCULAR SYSTEM
1248
INFORMATION ON ACTIVE AND/OR SOLUTION CONFORMATION OF NPs
1249
BIOLOGICAL ACTIONS OF NPs IN THE CARDIOVASCULAR SYSTEM
1249
PATHOPHYSIOLOGICAL IMPLICATION OF NPs IN THE CARDIOVASCULAR SYSTEM
1250
References
1252
166: Urotensin and Its Related Peptides
1255
ABSTRACT
1255
INTRODUCTION
1255
UROCORTIN (UROTENSIN I)
1255
UROTENSIN II
1257
CONCLUSION
1258
References
1258
167: Vasoactive Intestinal Peptide
1261
ABSTRACT
1261
INTRODUCTION
1261
DISCOVERY
1262
DISTRIBUTION
1262
PROCESSING
1262
RECEPTORS
1263
BIOLOGICAL ACTIONS
1264
PATHOPHYSIOLOGY
1266
Acknowledgments
1267
References
1267
168: Cardiovascular Peptides: Vasopressin
1269
ABSTRACT
1269
DISCOVERY
1269
STRUCTURE OF THE PRECURSOR mRNA/GENE
1269
DISTRIBUTION OF THE mRNA
1269
PROCESSING
1269
RECEPTORS
1270
ACTIVE OR SOLUTION CONFORMATION
1270
BIOLOGICAL ACTIVITY
1270
PATHOPHYSIOLOGICAL IMPLICATIONS
1271
References
1272
XV: Renal Peptides Section
1273
169: Renal Effects of Neurohypophyseal Peptides
1273
ABSTRACT
1273
BRIEF HISTORY AND OVERVIEW OF THE NEUROHYPOPHYSEAL PEPTIDES
1273
BODY FLUID HOMEOSTASIS
1274
VASOPRESSIN AND OXYTOCIN RECEPTORS
1274
LOCALIZATION OF VASOPRESSIN AND OXYTOCIN RECEPTORS IN THE KIDNEY
1275
RENAL EFFECTS OF VASOPRESSIN
1275
RENAL EFFECTS OF OXYTOCIN
1277
References
1277
170: Renal Renin-Angiotensin System
1281
ABSTRACT
1281
INTRODUCTION
1281
DISTRIBUTION OF RENIN, ANGIOTENSINCONVERTING ENZYME, AND ANGIOTENSINOGEN IN THE KIDNEY
1281
INTRARENAL LEVELS OF ANGIOTENSIN II
1284
BIOLOGICAL ACTIONS OF INTRARENAL ANG II
1285
CONCLUSION
1286
References
1286
171: Renal Natriuretic Peptide System and Actions of Urodilatin
1289
ABSTRACT
1289
DISCOVERY AND FIRST DESCRIPTIONS OF URODILATIN
1289
METABOLISM OF URODILATIN IN THE KIDNEY AND ITS PHYSIOLOGICAL AND PHARMACOLOGICAL SIGNIFICANCE
1292
URODILATIN—CLINICAL IMPLICATIONS
1293
References
1294
172: ANP and Its Role in the Regulation of Renal Tubular Transport Processes
1297
ABSTRACT
1297
DISCOVERY OF ATRIAL NATRIURETIC PEPTIDE ACTIONS IN THE KIDNEY
1297
EFFECTS OF ANP ON TUBULAR TRANSPORT SYSTEMS
1297
References
1301
173: Adrenomedullin as a Renal Peptide
1303
ABSTRACT
1303
ADRENOMEDULLIN PEPTIDE
1303
AM RECEPTOR
1303
RENAL BIOLOGICAL ACTIONS OF AM
1304
RENOPROTECTIVE ACTIONS OF AM
1304
CLINICAL IMPLICATIONS OF AM IN ASSOCIATION WITH THE KIDNEY
1304
References
1305
174: Adrenomedullin 2/Intermedin
1309
ABSTRACT
1309
DISCOVERY
1309
STRUCTURE OF THE PRECURSOR mRNA AND GENE
1310
DISTRIBUTION OF mRNA
1312
PROCESSING OF THE PRECURSOR
1312
RECEPTORS AND SIGNALING CASCADE
1312
PATHOPHYSIOLOGICAL IMPLICATIONS
1313
References
1314
175: Renal Endothelin
1315
ABSTRACT
1315
BRIEF HISTORY OF ENDOTHELIN
1315
LOCALIZATION OF THE ET-1 SYSTEM IN THE KIDNEY
1315
RENAL HEMODYNAMIC EFFECTS OF ET-1
1316
ET-1 EFFECTS ON EXCRETORY FUNCTION
1316
RENAL ET-1 IN BLOOD PRESSURE REGULATION
1318
CONCLUSION
1319
References
1319
176: Prolactin and Kidney Function
1323
ABSTRACT
1323
INTRODUCTION
1323
CLASSICAL PRODUCTION SITE AND ACTIONS OF PROLACTIN
1323
PROLACTIN RECEPTORS
1324
PROLACTIN AND OSMOREGULATION
1324
PROLACTIN RECEPTORS IN THE MAMMALIAN KIDNEY
1324
RENAL PRODUCTION OF PROLACTIN
1325
RENAL ACTIONS OF PROLACTIN
1325
PROLACTIN AND RENAL FUNCTION IN HUMANS
1326
THE JURY IS STILL OUT ON THE RENAL ACTIONS OF PROLACTIN
1326
HAVE TRANSGENE METHODS CLARIFIED THE ISSUE?
1327
References
1327
XVI: Respiratory Peptides Section
1329
177: Therapeutic Potential of Adrenomedullin for Pulmonary Hypertension
1329
ABSTRACT
1329
INTRODUCTION
1329
DISCOVERY, STRUCTURE, AND SYNTHESIS
1329
RECEPTORS AND THEIR DISTRIBUTION
1329
BIOLOGICAL ACTIONS
1330
CLINICAL APPLICATION OF AM FOR PULMONARY HYPERTENSION
1331
CONCLUSION
1333
References
1333
178: Endothelin in the Airways
1335
ABSTRACT
1335
INTRODUCTION
1335
SYNTHESIS AND ELIMINATION OF ET-1
1336
ENDOTHELIN RECEPTOR SUBTYPES AND LOCALIZATION
1336
PATHOPHYSIOLOGICAL ROLE
1336
References
1337
179: PACAP’s Role in Pulmonary Function
1339
ABSTRACT
1339
GENE STRUCTURE AND DISTRIBUTION OF THE PRECURSOR mRNA
1339
RECEPTORS
1339
BIOLOGICAL ACTIONS WITHIN THE LUNG
1340
PATHOPHYSIOLOGICAL IMPLICATIONS
1342
THERAPEUTIC POTENTIAL
1343
References
1344
180: Tachykinins and Their Receptors in the Lung
1347
ABSTRACT
1347
TACHYKININ RECEPTOR PHARMACOLOGY
1347
TACHYKININ LOCALIZATION IN THE LUNG
1348
TACHYKININ RECEPTOR DISTRIBUTION IN THE LUNG
1348
TACHYKININ-MEDIATED BIOLOGICAL EFFECTS IN THE LUNG
1348
THERAPEUTIC POTENTIAL OF TACHYKININ NK1 RECEPTOR BLOCKADE
1349
THERAPEUTIC POTENTIAL OF TACHYKININ NK2 RECEPTOR BLOCKADE
1349
THERAPEUTIC POTENTIAL OF DUAL TACHYKININ NK1-NK2 RECEPTOR BLOCKADE
1349
THERAPEUTIC POTENTIAL OF BLOCKADE OF THE TACHYKININ NK3 RECEPTOR
1350
CONCLUSION
1350
References
1350
181: Vasoactive Intestinal Peptide
1353
ABSTRACT
1353
INTRODUCTION: VIP IN THE LUNG
1353
VIP AND ITS FAMILY OF PEPTIDES
1353
DISTRIBUTION AND LOCALIZATION
1353
BIOLOGICAL ACTIONS PERTINENT TO THE LUNG
1354
RECEPTORS
1355
SIGNAL TRANSDUCTION PATHWAYS
1355
PHYSIOLOGICAL ROLES
1355
VIP IN PULMONARY DISEASE
1355
THERAPEUTIC POTENTIAL
1356
References
1357
XVII: Opioid Peptides Section
1359
182: Proenkephalin-Derived Opioid Peptides
1359
ABSTRACT
1359
DISCOVERY OF THE ENKEPHALINS
1359
STRUCTURE OF THE PRECURSOR GENE
1359
DISTRIBUTION OF ENKEPHALIN mRNA AND PEPTIDE
1359
PROCESSING
1360
RECEPTORS
1360
BIOLOGICAL ACTIVITY OF ENKEPHALINS
1361
PATHOPHYSIOLOGICAL IMPLICATIONS
1362
References
1363
183: Prodynorphin-Derived Opioid Peptides
1365
ABSTRACT
1365
DISCOVERY
1365
STRUCTURE OF THE PRECURSOR mRNA/GENE
1365
PROCESSING
1366
RECEPTORS
1367
CONFORMATIONAL ANALYSIS OF DYN A(1–17)
1367
DYNORPHIN EXPRESSION IN THE CENTRAL NERVOUS SYSTEM AND POSSIBLE BIOLOGICAL ACTIONS
1367
PATHOPHYSIOLOGICAL IMPLICATIONS
1368
DRUG ABUSE AND DYNORPHINS
1369
DYNORPHIN EXPRESSION IN PERIPHERAL TISSUES
1369
PERSPECTIVE
1370
References
1370
184: POMC Opioid Peptides
1371
ABSTRACT
1371
INTRODUCTION
1371
DISCOVERY
1371
DISTRIBUTION
1371
PROCESSING
1372
RECEPTORS
1373
BIOLOGICAL ACTIONS
1374
PATHOPHYSIOLOGICAL IMPLICATIONS
1376
References
1376
185: Endomorphins as Endogenous Peptides for u-Opioid Receptor: Their Differences in the Pharmacological and Physiological Characters
1379
ABSTRACT
1379
DISCOVERY OF ENDOMORPHINS
1379
DISTRIBUTION OF THE ENDOMORPHIN-2- LIKE IMMUNOREACTIVE NEURONS IN THE CENTRAL NERVOUS SYSTEM
1380
DISTRIBUTION OF THE EM-1-LI NEURONS IN THE CENTRAL NERVOUS SYSTEM
1380
RECEPTOR SELECTIVITY AND ITS MODULATION
1381
BIOLOGICAL ACTIONS OF ENDOMORPHINS
1381
PATHOPHYSIOLOGICAL IMPLICATIONS OF ENDOMORPHINS
1382
CONCLUSION
1383
Acknowledgments
1383
References
1383
186: Casomorphins and Hemorphins—Opioid Active Peptides Released by Partial Hydrolysis of Structural Proteins
1385
ABSTRACT
1385
DISCOVERY OF THE b-CASOMORPHINS AND THE HEMORPHINS
1385
THE FORMATION OF b-CASOMORPHINS AND HEMORPHINS
1386
RECEPTOR SELECTIVITY AND ITS MODULATION
1387
BIOLOGICAL ACTIONS AND FUNCTIONAL RELEVANCE OF THE b-CASOMORPHINS AND HEMORPHINS
1387
IMPLICATIONS OF b-CASOMORPHINS AND HEMORPHINS IN PATHOPHYSIOLGY
1388
CONCLUSION
1389
Acknowledgments
1389
References
1389
187: Anti-Opioid Peptides
1391
ABSTRACT
1391
INTRODUCTION
1391
REGULATION OF OPIOID ANALGESIA BY CCK
1391
CCK GENE EXPRESSION IN RESPONSE TO OPIOID ANALGESIA
1392
CCK RELEASE IN RESPONSE TO OPIOID ANALGESIA
1393
CELLULAR AND MOLECULAR MECHANISMS FOR CCK-OPIOID INTERACTIONS
1393
REGULATION OF OPIOID ANALGESIA BY NPFF
1393
REGULATION OF OPIOID ANALGESIA BY NOCICEPTIN
1394
REGULATION OF u-OPIOID SYSTEMS BY MIF-1, TYR-MIF-1, AND TYR-W-MIF-1
1394
Acknowledgment
1395
References
1395
188: Nociceptin
1397
ABSTRACT
1397
DISCOVERY
1397
STRUCTURE OF PRECURSOR MRNA/GENE
1397
DISTRIBUTION OF MRNA AND PEPTIDE
1399
BIOSYNTHESIS AND DEGRADATION
1400
RECEPTOR
1400
BIOLOGICAL ACTIONS
1400
PATHOPHYSIOLOGICAL IMPLICATIONS
1402
References
1402
189: Role of Tachykinins in Spinal Nociceptive Mechanisms and Their Interactions with Opioids
1405
ABSTRACT
1405
DISTRIBUTION OF TACHYKININS IN DORSAL ROOT GANGLIA AND THE SPINAL CORD
1405
PLASTICITY OF THE EXPRESSION OF TACHYKININS AND THEIR RECEPTORS FOLLOWING INFLAMMATION AND NERVE INJURY
1405
RELEASE OF TACHYKININS IN THE SPINAL CORD
1406
INVOLVEMENT OF TACHYKININS IN SPINAL NOCICEPTION
1406
NK-1 RECEPTOR AND NEUROPATHIC PAIN
1406
SP-SAPORIN AND NK-1 RECEPTOR EXPRESSING LAMINAE I NEURONS IN NOCICEPTION
1407
INTERACTION BETWEEN TACHYKININS AND OPIOIDS
1407
THE FAILURE OF NK-1 ANTAGONISTS AS ANALGESICS IN HUMANS
1407
References
1408
190: Exorphin-Opioid Active Peptides of Exogenous Origin
1411
ABSTRACT
1411
OPIOID PEPTIDES DERIVED FROM PLANT PROTEINS
1411
OPIOID PEPTIDES DERIVED FROM ANIMAL PROTEINS
1412
INTRAPROTEIN OPIOID SEQUENCE
1414
CLASSIFICATION OF EXORPHINS ACCORDING TO THEIR STRUCTURE
1414
OPIOID ANTAGONIST AND ANTI-OPIOID PEPTIDE DERIVED FROM PROTEINS
1415
CONCLUSION
1416
Acknowledgments
1416
References
1416
191: Opioid-Substance P Chimeric Peptides
1419
ABSTRACT
1419
INTRODUCTION
1419
CROSS-INTERACTION OF TACHYKININ AND OPIOID SYSTEMS
1420
TACHYKININ ANTAGONIST–OPIOID AGONIST CHIMERIC COMPOUNDS
1420
TACHYKININ AGONIST–OPIOID AGONIST CHIMERIC COMPOUNDS
1421
CONCLUSION
1423
References
1423
XVIII: Neurotrophic Peptides Section
1425
192: VIP- and PACAP-Related Neuroprotection
1425
ABSTRACT
1425
DISCOVERY
1425
STRUCTURE OF THE PRECURSOR mRNA, DISTRIBUTION, AND PROCESSING
1425
VIP NEUROPROTECTION
1425
RECENT RESEARCH ON VIP: CONCENTRATING ON RECEPTORS AND MECHANISMS
1426
RECENT RESEARCH ON PACAP
1427
NAP: TREATMENT THROUGH A VIP-RELATED MECHANISM
1428
CONCLUSION
1428
Acknowledgments
1428
References
1428
193: Insulin-Like Growth Factor 1
1431
ABSTRACT
1431
DISCOVERY
1431
STRUCTURE OF PRECURSOR mRNA/GENE
1431
DISTRIBUTION OF THE mRNA
1432
PROCESSING
1433
RECEPTORS
1433
ACTIVE AND/OR SOLUTION CONFORMATION
1434
BIOLOGICAL ACTIONS
1434
PATHOPHYSIOLOGICAL IMPLICATIONS
1435
References
1436
194: Erythropoietin—A Hematopoietic Hormone with Emerging Diverse Activities
1439
ABSTRACT
1439
DISCOVERY
1439
STRUCTURE OF THE PRECURSOR Epo mRNA/GENE
1439
DISTRIBUTION OF Epo mRNA
1439
PROCESSING OF Epo
1440
THE Epo RECEPTOR
1440
Epo BIOLOGICAL ACTIONS
1440
PATHOPHYSIOLOGICAL IMPLICATIONS
1444
References
1445
195: Neuregulins
1447
ABSTRACT
1447
DISCOVERY AND STRUCTURE
1447
DISTRIBUTION AND PROCESSING
1447
RECEPTORS
1448
BIOLOGICAL ACTIONS
1449
Acknowledgments
1450
References
1451
196: The Neurotrophins
1453
ABSTRACT
1453
DISCOVERY OF NERVE GROWTH FACTOR
1453
STRUCTURE OF THE mRNA/GENE
1453
DISTRIBUTION OF THE mRNA
1453
PRECURSOR PROTEIN: PROCESSING AND ACTIVITY
1454
CONFORMATION
1454
RECEPTORS—BINDING SITES
1455
TRKA AND p75 RECEPTORS—STRUCTURE
1455
RECEPTOR SIGNALING
1456
NEUROTROPHINS—RETROGRADE TRANSPORT
1456
p75 RECEPTOR SIGNALING
1457
NEUROTROPHINS—PHYSIOLOGICAL ROLE AND ROLES IN PATHOLOGY
1457
CLINICAL PROSPECTS
1458
References
1458
XIX: Blood-Brain Barrier Peptides Section
1461
197: Amino Acid Transport Across the Blood–Brain Barrier
1461
ABSTRACT
1461
BRAIN AMINO ACID REGULATION
1461
BLOOD–BRAIN BARRIER AMINO ACID TRANSPORT
1462
TRANSPORT SYSTEMS
1462
CONCLUSION
1466
References
1467
198: Oligopeptide Transport at the Blood–Brain and Blood–CSF Barriers
1469
ABSTRACT
1469
INTRODUCTION
1469
BLOOD–BRAIN BARRIERS: GENERAL PROPERTIES
1469
OLIGOPEPTIDE TRANSPORT AT THE BBB
1470
PEPTIDASES AT THE BBB
1471
OLIGOPEPTIDE TRANSPORTERS AT THE CHOROID PLEXUS
1471
PEPTIDASES AT THE CHOROID PLEXUS
1472
PEPTIDE AND PEPTIDOMIMETIC DRUG TRANSPORT
1472
CONCLUSION
1473
Acknowledgments
1474
References
1474
199: Opiate Peptides and the Blood–Brain Barrier
1475
ABSTRACT
1475
INTRODUCTION
1475
STABILIZATION
1475
TARGETING
1476
CONCLUSION
1478
References
1478
200: Permeability of the Blood–Brain Barrier to Neurotrophic Peptides
1481
ABSTRACT
1481
INTRODUCTION
1481
METHODS TO STUDY PERMEATION OF PEPTIDES ACROSS THE BBB: IN VIVO AND IN VITRO MODELS
1481
BINDING PROTEINS THAT AFFECT THE STABILITY AND PERMEATION KINETICS: INTRAVENOUS DELIVERY VERSUS IN SITU BRAIN PERFUSION
1482
PRESENCE OF RECEPTORS AT THE APICAL OR BASOLATERAL SURFACE OF THE BBB: USEFUL OR NOT FOR PEPTIDE TRANSPORT?
1483
ADSORPTIVE ENDOCYTOSIS AND CHEMICAL MODIFICATIONS THAT ENHANCE DELIVERY ACROSS THE BBB
1483
THE INTRACELLULAR TRAFFICKING OF PEPTIDES THAT LEADS TO EXOCYTOSIS
1483
SPECIFIC EXAMPLES OF THE PHARMACOKINETICS OF BBB PERMEATION
1484
THE SITUATION OF THE PARTIALLY DISRUPTED BBB AND SELECTIVE REGULATION OF THE TRANSPORT SYSTEM IN PATHOPHYSIOLOGY
1484
ENHANCED DELIVERY OF NEUROTROPHIC PEPTIDES: HOW IT AFFECTS NEUROREGENERATION
1485
CONCLUSION
1485
Acknowledgment
1485
References
1485
201: Transport of Basic Peptides at the Blood–Brain Barrier
1489
ABSTRACT
1489
INTRODUCTION
1489
bFGF
1490
TRANSPORT MECHANISM
1492
PEPTIDE DELIVERY TO THE BRAIN VIA ADSORPTIVE-MEDIATED TRANSPORT
1492
CONCLUSION
1492
Acknowledgments
1492
References
1493
202: Fibroblast Growth Factor and the Blood–Brain Barrier
1495
ABSTRACT
1495
INTRODUCTION
1495
FGF-INDUCED PROTECTION OF CEREBRAL ENDOTHELIUM AND NEURONS
1496
FGF1 AND FGF2 TRANSPORT ACROSS THE BLOOD–BRAIN BARRIER
1496
FGF SECRETION BY MICROVASCULAR ENDOTHELIAL CELLS
1497
FGF MODULATION OF CEREBRAL ENDOTHELIAL CELLS
1497
FGF2 TRANSPORT AND REGULATORY PHENOMENA AT THE CHOROID PLEXUS
1497
THE CSF-EPENDYMAL-BRAIN INTERFACE
1498
MODELING OF PEPTIDE REGULATORY SYSTEMS: INTEGRATING MULTIPLE LIGANDS AND TRANSPORT INTERFACES
1498
CONCLUSION
1499
References
1499
203: Ingestive Peptides and the Blood–Brain Barrier
1501
ABSTRACT
1501
INTRODUCTION
1501
INSULIN
1501
LEPTIN
1502
GHRELIN
1503
OTHER INGESTIVE PEPTIDES AND PROTEINS: SPECIAL INTERACTIONS WITH THE BBB
1503
CONCLUSION
1504
References
1505
204: Functional Aspects of Vasoactive Peptides at the Blood–Brain Barrier
1507
ABSTRACT
1507
ANGIOTENSIN
1507
BRADYKININ
1508
INTERPLAY BETWEEN ANGIOTENSIN AND BRADYKININ
1509
SUBSTANCE P
1509
ATRIAL NATRIURETIC PEPTIDE
1510
ENDOTHELINS
1510
ADRENOMEDULLIN
1511
MISCELLANEOUS PEPTIDES WITH VASOACTIVE PROPERTIES IN THE CNS
1511
References
1512
205: Hypothalamic Neuropeptides and the Blood–Brain Barrier
1515
ABSTRACT
1515
INTRODUCTION
1515
THE CIRCUMVENTRICULAR ORGANS
1515
TRH
1516
GnRH
1516
CORTICOTROPIN-RELEASING HORMONE
1517
VASOPRESSIN (ANTIDIURETIC HORMONE)
1517
OXYTOCIN
1518
SOMATOSTATIN
1518
PACAP
1518
References
1518
206: Diseases Mediated by the BBB: From Alzheimer’s to Obesity
1521
ABSTRACT
1521
INTRODUCTION
1521
LEPTIN AND OBESITY
1521
AMYLOID b PROTEIN EFFLUX AND ALZHEIMER’S DISEASE
1522
METHIONINE ENKEPHALIN AND ALCOHOL WITHDRAWAL
1523
GLUT-1 DEFICIENCY SYNDROME
1523
INSULIN RESISTANCE IN SEPSIS
1524
CONCLUSION
1524
References
1524
XX: Other Peptide Topics
1527
207: Prebiotic Peptides
1527
ABSTRACT
1527
INTRODUCTION
1527
THE PRIMITIVE EARTH SCENARIO
1527
THE FORMATION OF AMINO ACIDS
1528
THE FORMATION OF PEPTIDES
1528
A PEPTIDE WORLD AS THE ORIGIN OF LIFE?
1530
References
1531
208: Mixture-Based Combinatorial Libraries
1533
ABSTRACT
1533
INTRODUCTION
1533
GENERAL METHODS
1533
m-RECEPTOR LIGANDS
1535
d-RECEPTOR LIGANDS
1536
k-RECEPTOR LIGANDS
1536
m-, d-, AND k-LIGANDS
1536
ORPHAN RECEPTOR LIGANDS
1536
TESTING MIXTURES IN VIVO
1537
CONCLUSION
1537
FUTURE STUDIES
1538
References
1538
209: Use of Synthetic Peptides for Structural and Functional Analyses of Viruses Like HIV
1541
ABSTRACT
1541
INTRODUCTION
1541
HIV-1-DERIVED SYNTHETIC PEPTIDES
1541
THE HIV-1-SPECIFIC VIRUS PROTEIN U
1542
STRUCTURE AND FUNCTION OF THE LENTIVIRAL PROTEIN R
1543
THE TRANS-ACTIVATOR OF TRANSCRIPTION (Tat) OF HIV-1
1544
THE HIV-1 PROTEASE
1545
THE HIV-1 p6 Gag PROTEIN
1546
THE HIV-1 Gag PROTEINS NC AND MA
1547
CONCLUSION
1547
Acknowledgments
1548
References
1548
210: Pheromone Peptides
1551
ABSTRACT
1551
INTRODUCTION
1551
BACTERIAL PHEROMONE PEPTIDES
1552
FUNGAL PHEROMONE PEPTIDES
1552
ARTHROPOD PHEROMONE PEPTIDES
1555
ANNELID PHEROMONE PEPTIDES
1556
MOLLUSK PHEROMONE PEPTIDES
1556
VERTEBRATE PHEROMONE PEPTIDES
1556
CONCLUSION
1557
References
1557
211: Fish Peptides
1561
ABSTRACT
1561
INTRODUCTION
1561
MELANIN-CONCENTRATING HORMONE
1561
UROTENSINS
1562
ADRENOMEDULLIN 2/INTERMEDIN
1562
STANNIOCALCINS
1563
CONCLUSION
1564
References
1564
212: Peptides and Sleep
1567
ABSTRACT
1567
INTRODUCTION
1567
HYPOTHALAMIC-PITUITARY-SOMATOTROPIC SYSTEM
1567
HYPOTHALAMIC-PITUITARYADRENOCORTICAL SYSTEM
1569
ACTH
1569
HYPOTHALAMIC-PITUITARY-THYROID SYSTEM
1570
OTHER PEPTIDES
1570
CONCLUSION
1571
Acknowledgment
1572
References
1572
213: Peptide Chronomics
1575
ABSTRACT
1575
PREAMBLE
1575
INTRODUCTION
1575
AVOIDING BLUNDERS
1578
CHRONOMICS SPAWNED BY CHRONOBIOLOGY MAPS DYNAMICS
1581
END POINTS
1581
SUSCEPTIBILITY RHYTHMS
1588
ATLAS
1588
BEGINNINGS OF OPPORTUNISTIC MAPPING ALONG THE SCALE OF YEARS
1588
MAPS OF PEPTIDES IN MEN
1593
PEPTIDE CHRONOMICS IN WOMEN
1593
BREAST CANCER RISK ASSESSMENT
1599
PROSTATE CANCER RISK ASSESSMENT
1599
DISCUSSION
1602
CONCLUSION
1603
Acknowledgments
1607
References
1607
Index
1611
Color Plates
1643
Alle Preise verstehen sich inklusive der gesetzlichen MwSt.